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Tiivistelmä 
Optiset biosensorit ovat saaneet arvostusta lukuisissa käyttökohteissa, kuten 
lääketeollisuudessa ja kliinisessä diagnostiikassa, biologisen tunnistuselementin korkean 
spesifisyyden ja optisen detektiomenetelmän non-invasiivisuuden ansiosta. Optisen 
biosensorien tehokas ja joustava käyttö kuitenkin edellyttää, että käyttäjä ymmärtää näiden 
toiminnan fysikaalisia, kemiallisia ja biologisia perusperiaatteita sekä optisten menetelmien 
etuja ja rajoituksia. Tutkielman kirjallinen osa tutustuttaa biosensoreiden ja biosensoroinnin 
perusteisiin sekä esittelee erään optiseen pintaplasmoniresonanssiin (surface plasmon 
resonance, SPR) perustuvan laitteiston toimintaa, etuja ja haasteita. 
Tutkielman kokeellisissa osuuksissa käytettiin multiparametrista SPR-laitteistoa (MP-SPR), 
joka kykenee mittaamaan molekyylien adsorption lisäksi laajasti näytteen optisia 
ominaisuuksia. Proteiiniliuoksien konsentraatiot sekä niiden puhtausasteet määritettiin UV-
Vis-spektrofotometrilla. 
Tutkielman ensimmäinen kokeellinen osuus osoitti switchavidiiniin (neutralisoitu 
avidiinimutantti) ja proteiini G molekyyleihin perustuvan regeneroitavan 
immunosensorointipinnan toistettavuuden ja vertailtavuuden. Lisäksi sensorointipinta osoitti, 
että proteiinien non-spesifinen sitoutuminen on erittäin vähäistä eräillä malliproteiineilla 
tutkittaessa. IgG-molekyylien immobisaation toimivuudesta ei kuitenkaan saatu luotettavia 
tuloksia. Lisäksi tutkielma esittää switchavidiinille MP-SPR mittausdataan perustuvan 
mekaanisen sitoutumismallin. Jatkotutkimuksissa voitaisiin keskittyä monimutkaisempien 
näytteiden mittaamiseen sekä kehittää esitettyyn sitoutumismalliin perustuvaa automaatiota. 
Tutkielman toinen kokeellinen osuus tutki nelikanavaisen MP-SPR-prototyypin soveltuvuutta 
nopeasti sitoutuvien pienlääkemolekyylien sitoutumisen mittaamiseen. Ihmisen 
hiilihappoanhydraasi II-entsyymiä immobilisoitiin kolmiulotteiseen hydrogeelimatriksiin ja 
kolmen sulfonamidi-inhibiittorin sitoutumiskinetiikkaa vertailtiin referenssiartikkelin 
tuloksiin. Tutkimuksessa onnistuttiin mittaamaan ja analysoimaan kineettiset vakiot vain 
yhdestä inhibiittorista (asetatsoliamidi). Johtopäätöksenä MP-SPR-prototyyppi kykenee 
mittaamaan pienmolekyylien nopeaa sitoutumiskinetiikkaa, mutta tämän edellytyksenä on 
erittäin tarkka näytteiden ja puskureiden valmistus sekä bulkkivasteiden oikeaoppinen 
kalibraatio. 
Avainsanat: pintaplasmoniresonanssi, kliininen diagnostiikka, farmakodynamiikka, assay-
kehitys, sitoutumiskinetiikka, avidiini-biotiini-teknologia pienlääkemolekyylit, proteiinien 
adsorptiomallit 
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Abstract 
Optical biosensors have gained high regard in the field of drug industry and clinical diagnostics 
owing to the high specificity of biological recognition elements as well as to the non-
invasiveness of optical detection methods. The flexible and efficient use of optical biosensors, 
however, requires that the user understands their basic physical, chemical, and biological 
principles as well as the advantages and limitations of these devices. The literature review 
introduces the fundamentals of biosensing and biosensors, and describes the principles, 
advantages and challenges related to one type of surface plasmon resonance (SPR) device. 
In the experimental part of the thesis, a multiparametric SPR (MP-SPR)-system was used to 
measure the optical properties of samples in addition to the traditional adsorption of molecules. 
The concentrations and purity of protein solutions were determined by a UV-Vis 
spectrophotometer. 
The first experimental part showed the reproducibility and repeatability of a regenerable IgG-
sensing surface prepared using switchavidin (a neutralized avidin mutant) and protein G 
molecules. Furthermore, the sensing surface has ultralow fouling ability against some common 
model proteins. The immobilization of IgG-molecules did not show, however, reliable results. 
Additionally, the thesis represents a mechanical model for the switchavidin adsorption that is 
based on the MP-SPR measurement data. Further research could concentrate on the 
measurement of more complex samples as well as on the development of automation that is 
based on the represented mechanical adsorption model. 
The second experimental part studied the applicability of a four-channel MP-SPR prototype 
into the measurement of fast association kinetics of small molecular weight (MW) drugs.  
A human carbonic anhydrase II enzyme was immobilized into a three-dimensional hydrogel 
matrix and the interaction kinetics of three sulfonamide inhibitors were compared with kinetic 
values in the literature. Only a single inhibitor (acetazolamide) gave satisfying results. In 
conclusion, the MP-SPR-prototype is capable of measuring the fast association kinetics of small 
MW drugs, but this requires the very accurate preparation of samples and buffers as well as the 
proper calibration of bulk responses. 
Keywords: surface plasmon resonance, clinical diagnostics, pharmacodynamics, assay 
development, interaction kinetics, avidin technology, small drug molecules, adsorption models 
of proteins 
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ABBREVIATIONS 
α-CA α-class carbonic anhydrase enzyme 
AZE Acetazolamide 
BAT Biotin-terminated alkanethiol 
b-SAM Biotinylated self-assembled monolayer 
b-SLB Biotinylated supported lipid bilayer 
4-CBS 4-sulfamoylbenzoic acid 
CMD Carboxymethyl-dextran 
CV Coefficient of variation 
DLS Dynamic light scattering 
DMSO Dimethyl sulfoxide 
EDC N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
ELISA Enzyme-linked immunosorbent assay 
FC Flow channel 
hCAII Human carbonic anhydrase II enzyme 
h-IgG Immunoglobulin gamma from human blood serum 
LOD Limit of detection 
LSPR Localized surface plasmon resonance 
MAT Matrix alkanethiol 
mDeg Millidegree unit of angle 
MES 2-(N-morpholino)ethanesulfonic acid 
MP-SPR Multiparametric surface plasmon resonance  
MSU Methanesulfonamide 
MTL Mass transport limitation 
MW Molecular weight 
MWCO Molecular weight cutoff 
NCAvd Neutralized chimeric avidin  
NHS N-hydroxysuccinimide 
NP Nanoparticle 
PDMS  Poly(dimethylsiloxane) 
PEEK Poly(ether ether ketone) 
PMI SPR peak minimum intensity 
QCM-D Quartz crystal microbalance with dissipation 
RI Refractive index 
RT Room temperature 
RU Response unit 
SD Sample standard deviation 
SDS Sodium dodecyl sulfate 
SE Spectroscopic ellipsometry 
SPR Surface plasmon resonance 
TIR Total internal reflection 
UV-Vis Ultraviolet – visible light (spectrum) 
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1 INTRODUCTION 
The drug research and clinical diagnostics have exploited the natural binding mechanisms of 
biomolecules for several decades (Clark 1956). In biosensing technology, the use of biological 
recognition elements (i.e. ligand) usually results in the high affinity and specificity of analyte 
binding. This also enables the determination of biological activity with interaction kinetics that 
is practically impossible with chemical sensors. When the generated signal is transduced from 
an optical format into an electrical current, the detection system does not affect the properties 
of the sample. The flexible and effective use of optical biosensors, however, requires biological, 
chemical, and physical knowledge about the design and function of the optical biosensing 
surfaces and instrumentation. The main purpose of this thesis is to give a theoretical background 
about the principles of optical biosensing and the construction of a functional bioassay. 
Furthermore, it depicts the practical benefits and disadvantages of optical real-time biosensing 
using a unique multiparametric surface plasmon resonance (MP-SPR) instrumentation from 
BioNavis Ltd. The MP-SPR system simultaneously follows the scattering and absorbance 
properties of the adsorption layer as well as the bulk changes in addition to the traditional SPR 
peak minimum angle (Viitala et al. 2013). 
Trustful and repeatable measurement of biomarkers from complex media such as blood serum 
requires an accurate, precise, and reproducible sensing system with anti-fouling and 
regeneration properties. To reach these goals, an optical immunosensor, which utilizes 
biotinylated protein G and switchavidin molecules to orient IgG molecules and to achieve 
separate regeneration steps for the IgG layer and the layers above it, had been designed by 
numerous research groups (Pollheimer et al. 2013). The experiments conducted in the first 
experimental part of this thesis adapted the protocol described in the article of  
Zauner et al. 2016 to reconstruct, assess, and optimize the immunosensing platform using the 
MP-SPR detection system.  
The α-class carbonic anhydrases (α-CAs) that are found from mammals have significant roles 
in numerous physiological and pathological processes, such as pH and CO2 homeostasis, 
biosynthetic reactions, tumorigenicity, and electrolyte secretion in multiple tissues/organs 
(Rogez‐Florent et al. 2014). Logistically, humans have several isoforms of α-CAs with separate 
functions in distinct locations in many tissues/organs. This underlines the importance of 
directed research that is focused on designing highly target-selective inhibitors to minimize the 
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side effects of drugs. The traditional way to collect only thermodynamic data, such as a 
dissociation constant (KD), leads to a loss of valuable information that would otherwise enhance 
the process of drug discovery, or explain the rapid course of a disease as well as the resistance 
to drug therapy. The unavoidable challenge, however, arises from the fast association kinetics 
of sulfonamide inhibitors combined with the small molecular weight (MW). In the second 
experimental part of this thesis, the interaction kinetics of the human carbonic anhydrase 
(hCAII) enzyme with the sulfonamide inhibitors was studied in order to test the kinetic limits 
of a four-channel MP-SPR prototype, and to verify the fast association kinetics of sulfonamide 
inhibitors using the angular scan mode of MP-SPR instrumentation. The experiments followed 
the protocol described in an article of Papalia and colleagues in 2006 with minor modifications. 
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2 LITERATURE REVIEW  
2.1 Fundamentals of optical biosensing 
Optical biosensors are immune to electromagnetic interference, they enable the multiplexed 
detection of an analyte, and without labels they do not affect the sample per se (Guo 2012). 
These characteristics make the optical biosensor a considerable option in various areas from 
drug research and environmental safety to food industry and clinical diagnostics to construct a 
highly sensitive, relatively inexpensive, and rapid detection system for the quantitative and 
qualitative data of molecular interaction (Homola 2008). The flexible and effective use of 
optical biosensors requires biological, chemical, and physical knowledge about the design and 
function of the optical biosensing surfaces and instrumentation. The following sections present 
the operation principle, the general definitions, and the basic assay formats related to optical 
biosensors. They also introduce different approaches to biofunctionalize the sensing surface 
and to prevent the non-specific adsorption of proteins (i.e. fouling). Furthermore, the end of this 
chapter describes the essential binding kinetics and thermodynamics of ligand – analyte 
interactions. 
2.1.1 Operation principle and definitions 
A biosensor is an analytical device that produces quantitative or semi-quantitative information 
about a specific ligand – analyte interaction (Thévenot et al. 2001). It integrates a biological 
recognition element i.e. ligand, such as antibody, into direct contact with a transducer. In the 
optical biosensor, the optical transducer converts the generated signal response of the 
biomolecule binding event to an optical format. The read-out and analysis of the optical signal 
is performed using a detector and a computer or an equivalent smart device. 
The specificity and selectivity of a biosensing system rely correspondingly on the ability of the 
biological element to interact strongly with the analyte molecules, and to filter out the rest of 
the sample components without significant interaction (IUPAC 2014). When the ligand 
molecules are immobilized in direct contact with the surface of the transducer, the sensitivity 
can be determined as efficiency of the sensing system to generate a signal as a function of the 
concentration. The sensitivity of the sensing system is mainly dependent on the amount, 
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orientation, and affinity of the biological recognition element as well as on the performance of 
the transducer (Cooper 2002). 
In practice, the non-specific binding between dissimilar and similar particles and surfaces 
masks the specific binding sites resulting in the loss of sensitivity in some extent. If the non-
specifically and specifically binding particles accumulate and saturate the sensing surface, the 
upper limit of the dynamic range is reached and the sensing surface needs to be regenerated to 
recover the binding ability of the biosensor. The dynamic range is specified as a range of 
concentration that can be quantified reliably (IUPAC 2014). The resolution of the sensing 
system designates the limit for the statistical distinction between two measurement points. 
According to the IUPAC definition (IUPAC 2014), the instrumental noise is an irregular 
fluctuation in the signal, which originates from the instrumentation of a biosensor. The baseline 
(or background) of the measurement, which is affected by the experiment conditions, the assay 
design, and the instrumental noise, is quantified by measuring a blank solution i.e. sample 
solution without the analyte of interest. The limit of detection (LOD) can be derived from the 
baseline by multiplying the standard deviation of the baseline signal by three.  
From the statistical point of view, the repeatability is the closeness of independently measured 
results produced by the same operator for the same sample using an identical apparatus under 
the same experiment conditions after a short interval of time. The reproducibility is an external 
complement to the repeatability: the measurements are conducted for the same sample with the 
same method, but the operator, apparatus, and laboratory are different. (IUPAC 2014) 
2.1.2 Assay formats 
The biosensing surfaces can be designed by applying different basic approaches with general 
benefits and disadvantages. The simplest approach is the direct assay, where the ligand 
molecules are immobilized on the sensor surface and then the analyte molecules are incubated 
with the ligand or they are introduced on the surface in the flow buffer (Schasfoort 2017). The 
signal response is directly proportional to the concentration of the analyte. Additional features, 
such as regeneration ability, can be achieved by adding mediator molecules showing 
irreversible affinity of binding.  
In some cases, when the immobilization of the ligand is challenging e.g. due to the deactivation 
of the ligand or the steric hindrance of analyte binding sites, one can switch the roles of the 
 5 
ligand and the analyte to construct an inhibition assay (Helmerhorst et al. 2012). The analyte 
molecules are immobilized on the surface, and a sample solution containing an unknown 
amount of analyte is mixed with a suitable amount of ligand (Schasfoort 2017). During the 
introduction of the sample mixture, the surface-attached analyte molecules and free analyte 
molecules of the sample solution compete from the binding sites of the ligand molecules. 
Therefore, the signal response is inversely related to the concentration of the analyte (indirect 
assay). In other words, the low concentrations of the analyte in the sample results in a high 
signal response, and vice versa. 
When the analyte has a small MW and does not generate a signal high enough, as is often the 
case for the sulfonamide inhibitors, a competitive assay may provide a solution. The sample 
solution containing the analyte is mixed with a specific amount of label-conjugated analyte, and 
the signal is generated when the label-conjugated and original analyte molecules in the sample 
solution compete for the binding sites of the surface-bound ligands. The signal response is 
inversely proportional to the concentration of the analyte. In optical biosensors, the label should 
have detectable intrinsic (e.g. high refractive index, RI; or MW) or inducible  
(e.g. fluorescence) properties (Guo 2012). 
If the competitive assay does not alleviate the problem with signal level, one can construct a 
sandwich assay, where the generated signal coming from a direct assay is amplified for instance 
using gold nanoparticle- or latex particle-conjugated antibodies (Schasfoort 2017). The latter 
solution is a microfluidic version for the traditional enzyme-linked immunosorbent assay 
(ELISA) format (Weng et al. 2016). The addition of an amplifier in SPR applications may 
complicate the data analysis and sometimes result in false negatives, but it may also increase 
the sensitivity and lower the limit of detection, which is essential when analytes are measured 
in complex matrices at extremely low concentrations (Mariani and Minunni 2014). It is worth 
to notice, however, that bulky molecules lead to a more unstable sensing surface, and in optical 
methods, where an evanescent field is present, they also lower the sensitivity of the biosensing 
system  
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2.1.3 Biofunctionalization 
The main advantage of biosensors is the use of a biological recognition element (i.e. ligand) 
that mimics the natural binding mechanisms usually with high affinity and specificity. This 
enables the determination of the biological activity using interaction kinetics. The sensing 
surfaces can be biofunctionalized by immobilizing ligands directly, or via a linker  
(e.g. His-tag) or mediator molecules (e.g. avidin protein) on the transducer surface  
(Homola 2008). The immobilization of ligands can also be performed for example on a two-
dimensional planar surface (e.g. a self-assembled monolayer i.e. SAM deposited onto the 
transducer surface) or into a three-dimensional hydrogel (e.g. carboxymethylated dextran i.e. 
CMD).  
SAM layers increase the degrees of freedom of a ligand, which correspondingly increase the 
probability of analyte binding (Mariani and Minunni 2014). In the case of commonly used 
mercaptoalkyls, the defects on a transducer surface affect the deposition of SAM surfaces, and 
they may cause local non-specific binding (shown in step 1 of Figure 1), or the deactivation of 
otherwise active and well-oriented ligand molecules (Schasfoort 2017). One alternative to 
alleviate this problem was seen in the article published by Zauner et al. in 2016, where the 
terminal ends of long-chain mercaptoalkyls had been linked to polyethylene glycol chains to 
smooth the sample solution-contacting surface. 
Three-dimensional hydrogels provide significantly higher ligand density for the immobilization 
than two-dimensional sensing surfaces, where the ligand density is restricted to a maximum of 
one monolayer (roughly 1-2 ng mm-2) (Schasfoort 2017). Furthermore, they provide protection 
against air bubbles and contaminants. Thick matrices may, however, distort the observed 
dissociation rate of an analyte as rebinding and diffusion-limited kinetics of the analyte may 
occur (Schasfoort 2017). Additionally, the excessive activation of carboxylated 
polysaccharides, such as CMD, by a frequently used non-specific EDC/NHS amine coupling 
chemistry may damage or prevent analyte binding by matrix crosslinking as well as increase 
the hydrophobicity of the matrix too much and precipitate the immobilized proteins. EDC and 
NHS are commonly used abbreviations for N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride and N-hydroxysuccinimide, respectively.  
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The optimal performance of the sensing system in terms of sensitivity and reliability is achieved 
when the ligand molecules are immobilized homogeneously in an oriented-fashion at suitable 
surface density with stable immobilization chemistry that does not affect the activity or 
conformation of ligand molecules (presented in the left side of Figure 1) (Guo 2012;  
Trilling et al. 2013). In the real world, instability, miss-folding, cross-linking (step 4 in 
Figure 1), and non-specific binding of the ligand (step 3) as well as the imperfections of the 
immobilization matrix or surface, poor selectivity of the immobilization chemistry (step 2), and 
competing or interfering molecules (step 1), to mention but a few, lead to a notably lower 
sensitivity of the sensing system.  
The immobilization methods of ligands and mediator molecules include entrapment and 
adsorptive immobilization as well as affinity binding and covalent coupling (Brena et al. 2013). 
In the entrapment method, the ligand molecules are permanently included into  
a polymeric network called matrix with non-covalent bonds, but the analyte molecules are free 
to enter and exit this matrix. The ligand leakage from the matrix may, however, compromise 
the reliability and operating time of such sensing surface.  
 
 
Figure 1. Schematic illustration of a truthful sensing surface. The analyte molecule may diffuse 
near the well-oriented and active ligand, and pass over the ligand molecules that are adsorbed 
non-specifically either to competing molecules, such as protein clusters (1) or the hydrophobic 
parts of SAM components (2). Additionally, the analyte molecule is not able to interact with a 
blocked binding site of the ligand molecules (3) as well as with the misfolded or denatured 
ligand molecules (4). The gold-facing thiol groups and hydrophilic head groups of the SAM are 
illustrated with grey and purple dots, respectively. The figure was recreated based on the 
illustration presented by Choi and Chae in 2010. The figure is not in scale. 
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Adsorbed ligand molecules are in turn immobilized non-specifically on the sensing surface by 
hydrogen bonding, van der Waals forces, ionic binding, and entropy-driven hydrophobic 
interactions (Schasfoort 2017). The drawbacks of this simple immobilization method are that 
non-specifically immobilized ligands compete with the non-specifically binding contaminants 
from the interactions with the sensing surface, and less than 10% of the immobilized ligand is 
in the active state as well as available for the interaction with the analyte. 
The well-defined and specific affinity binding of complementary mediators can be utilized to 
immobilize ligands in a reproducible and efficient way. This method is, however, expensive 
and requires more expertise and optimization from the operator. (Schasfoort 2017) 
The covalent immobilization enables the stable binding of ligands on a planar surface or into a 
three-dimensional matrix either with a specific or non-specific interaction (Homola 2008). 
There are numerous immobilization chemistries available for the different functional groups, 
such as thiols, amines, and aldehydes. The main challenges with the covalent immobilization 
arise when the optimization of immobilization conditions including the surface chemistry of 
the immobilization surface or matrix, the concentration of the ligand, and the reaction time of 
reagents, is required. The goal is to achieve a homogeneous sensing surface with a sufficient 
amount of active ligands at the same time preserving steric accessibility. The conjunction of 
protein-resistant surface designs with the covalent coupling of ligands may be complicated due 
the steric repulsion between the surface and ligand.  
One strength of the reversible immobilization is the opportunity to regenerate the sensing 
surface when necessary by alternating the ambient conditions, such as temperature, ionic 
strength, pH, or polarity of the solvent, and reconstructing the sensing surface with a fresh 
ligand (Brena et al. 2013). This reduces the cost per analysis and enables the evaluation of 
sensor-specific repeatability of measurements. Zauner et al. presented in 2016 a versatile 
approach, where a genetically engineered version of avidin and a biotinylated immunoglobulin-
binding protein (protein G) was utilized to construct a regenerative immunosensing platform 
without the use of harsh regeneration treatments. It has the capability to change specificity of 
the sensing surface or to remove all the proteins from the sensing surface depending on the use 
of two distinct regeneration solutions. 
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Tetrameric avidin and streptavidin molecules from chicken and Streptomyces avidinii, 
respectively, have been utilized broadly in the field of biomedicine, biotechnology, and 
biosensing owing to the formation of the extremely stable avidin-biotin complex 
(KD ≈ 10-14 – 10-16 M), and the robust structure that tolerates extensive mutation  
(Laitinen et al. 2006). Avidin and streptavidin molecules have been placed in the role of 
mediator (Trilling et al. 2013) and ligand with pronounced performance. The development of 
the biotin-avidin technology by rational protein engineering has produced novel mutants of 
avidin and streptavidin with tailor-made properties, such as neutralized surface charges and 
reversible binding (Laitinen et al. 2006). For example, switchavidin (avidin with five specific 
mutations) shows ultralow non-specific binding of proteins owing to the neutral isoelectric 
point (pI). It also enables the breakdown of specific interactions with biotin molecules using 
rapid (less than 10 min) and efficient chemical treatment (Pollheimer et al. 2013).  
2.1.4 Anti-fouling ability of biosensing surface 
The decrease in the non-specific adsorption of sample components contributes positively to the 
sensitivity and reliability (lower number of false positives) of the biosensing system.  
The sample solution may contain amphiphilic proteins and peptides, water-soluble 
carbohydrates, and hydrophobic lipids in different combined forms e.g. in vesicles with integral 
proteins (Nallani et al. 2011). Consequently, the adsorption behavior of complex media may 
differ significantly from the adsorption behavior observed for the single biomolecule solutions, 
and the discussion of this section is limited to the non-specific adsorption of proteins i.e. to the 
fouling (Vaisocherová et al. 2015). The main challenge is to design an anti-fouling surface that 
enables the ligand molecules (mostly proteins) to be immobilized in an active state, but still 
rejects the non-specific adsorption of other protein components (Pop-Georgievski et al. 2013). 
The following paragraphs introduce some of the basic principles and factors affecting the 
protein adsorption phenomena, and the alternatives to improve the anti-fouling ability of 
biosensing surfaces. 
Numerous adsorption models exist for proteins, but as a compressed version, the adsorption of 
proteins usually follows a dynamic process called Vroman effect, where the high mobility 
proteins adsorb first onto a surface, and then they are replaced by the lower mobility proteins 
that show higher affinity (Vaisocherová et al. 2015). Proteins roll, spread, diffuse laterally, form 
clusters, and change conformation on the sensing surface in order to find the lowest possible 
energy state together with neighboring molecules (Barnes and Gentle 2011). 
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Most important factors affecting the protein adsorption are the surface energy, polarity, charge, 
and morphology (Barnes and Gentle 2011). Additionally, post-translational modifications, such 
as lipids and sugar groups, artificial chemical modifications, such as biotin residues, and 
conformational changes may alter the expected adsorption behavior. The pI of proteins and the 
ambient pH of sample solution defines the nature of electrostatic interactions with charged 
particles or surfaces. For instance, a positively charged surface attracts negatively net charged 
proteins (pH > pI) on the surface and vice versa. When pH equals pI, the net charge of the 
protein is neutral and the impact of the hydrophobic interactions on the adsorption behavior is 
higher. In biosensing, the electrostatic adsorption of undesired proteins can be controlled in 
some extent by alternating the pH conditions (Schasfoort 2017) or increasing the ionic strength 
of the sample solutions (Barnes and Gentle 2011), but the main limiting factors e.g. in the 
bioassays come from the properties of present proteins (ligands, mediators, fouling proteins) as 
well as from the surface chemistry of the sensing platform. 
The anti-fouling properties of the sensing surface are often evaluated using single protein 
solutions of HSA (or BSA), IgG, lysozyme, and fibrinogen (Vaisocherová et al. 2015). 
Fibrinogen is a relatively large (MW = 340 kDa) protein found from human blood-plasma and 
it adsorbs easily onto hydrophobic surfaces. Lysozyme, in turn, is a relatively small protein 
(MW = 14 kDa) with positive net charge at physiological conditions owing to a high pI (~12). 
It can be used to model the electrostatic adsorption of proteins onto surfaces. 
Numerous shared physicochemical properties of protein-resistant surfaces have been found: 
hydrophilicity, electroneutrality, lacking hydrogen-bond donors, and having hydrogen-bond 
acceptors to mention but a few. Consequently, the immobilization of the ligand mainly via 
physical adsorption e.g. ionic and hydrophobic interactions are not suitable for applications, 
where low-fouling properties are required. The high surface density and highly ordered 
structure of SAMs as well as the hydrophilic interface with the sample solution enhance the 
anti-fouling ability of the sensing surface. Oligo (ethylene glycol)-terminated SAM surfaces 
are commonly used in preliminary studies of bioassay development as they perform well in 
single-protein solutions, but they do not show adequate anti-fouling properties in more complex 
media, such as blood serum. (Vaisocherová et al. 2015) 
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Traditionally, the anti-fouling property of sensing surfaces have been improved by acetylation 
or succinylation of protein ligands. The statistical nature of these chemical modifications, 
however, produces an over-acetylated fraction of protein with reduced stability  
(Taskinen et al. 2014). Genetic engineering has been used as an alternative to chemical 
modifications, ultimately leading to more defined surface chemistry without significant loss of 
stability or activity. 
From the biosensing surface point of view, the anti-fouling properties of a sensing surface can 
be sometimes improved by blocking the surface, e.g. with BSA. The efficiency of this approach 
is based on the dense monolayer of a low mobility protein that can resist the adsorption of 
protein clusters (Rabe et al. 2011). However, the BSA blocking may result in the blockage of 
analyte entrance to the binding site of a ligand, and lower the sensitivity of sensing surface 
(presented in the step 3 of Figure 1). Furthermore, the BSA blocking layer, even a dense layer, 
may lack the capability to resist the penetration and spreading of protein clusters if the BSA 
blocking layer is deposited onto a too hydrophobic surface, or if there are surface defects on the 
gold layer (step 1 of Figure 1). This may lead to false negative or ambiguous responses, which 
are notably common challenges in the field of assay technology.  
As an alternative to the BSA blocking, one can add a protective barrier, such as a thick hydrogel 
or polymeric mesh, which prevents undesired sample components from protruding into the 
sensitive volume of the sensing surface (i.e. the volume where the evanescent field of SPR 
extends) (Schasfoort 2017). Bio-inert hydrogels lower the fouling levels also by electrostatic 
repulsion, when protein molecules approach the hydrogel and compress the equal-charges along 
the polymer chains. On the other hand, the protective barriers may lead to the mass transport 
limitation (MTL) of the analyte (described in section.  
It is also worth mentioning that the flow systems are better than the steady-state systems to 
avoid the non-specific adsorption of biomolecules (Schasfoort 2017). The contact time of 
sample solution with the sensing surface is shorter, which favors high affinity (fast association; 
high stability of ligand-analyte complex) interactions over low affinity (slow association; low 
stability of ligand-analyte complex) interactions. 
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2.1.5 Interaction kinetics 
The pharmacodynamic and pathological knowledge related to drug development and disease 
progression have been strong driving forces to develop fine-tuned instrumentations and analysis 
software for the measurement of interaction kinetics. In the first mentioned area, the kinetic 
measurements provide information on the formation speed and stability of the drug-target 
complex as well as a rough estimation for the effective dose of a drug. These factors can be in 
turn applied in the lead optimization process (Cooper 2002). In the second area, the affinity 
constant together with association and dissociation rate constants can explain for instance  
the rapid course of a disease as well as the resistance to drug therapy (Rutgers et al. 2000).  
The traditional way to solve only affinity between interacting molecules does not provide the 
whole picture. Figure 2 demonstrates how the same affinity values of different analytes may 
hide totally different kinetic profiles of the interaction. Notably, the equilibrium binding 
analysis of the interactions, however, supports the calculation of kinetic values. 
The ligand – analyte interaction kinetics consists of three steps (exemplified with the red kinetic 
curve in Figure 2): (1) an association phase, where analytes bind to the available binding sites 
of ligand molecules; (2) an equilibrium phase, where the rates of binding and dissociation are 
equal; and (3) a dissociation phase, where buffer flow has replaced the analyte solution, and  
the analyte molecules leave the binding sites of ligand molecules. 
 
Figure 2. The kinetic profiles for four analytes. They all have the same affinity with the ligand, 
but they show distinct velocities of (1) association and (3) dissociation (exemplified with the 
red kinetic curve). In the (2) equilibrium phase, the association and dissociation processes are 
in balance. The figure was recreated based on the plot presented in 
www.sprpages.nl/sensorgram-tutorial/a-curve; August 20, 2017. 
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When an increase in the analyte concentration does not generate any higher signal, the 
saturation point of the interaction is reached. If the buffer flow is incapable of removing analyte 
molecules from the binding sites of ligands i.e. the stability of ligand-analyte complex (kd) is 
practically too high for the serial injections of the analyte dilutions, a regeneration step (not 
shown in Figure 2) can be applied (Cooper 2002).  
The affinity between ligand and analyte molecules can be seen either thermodynamically as a 
transfer of heat and entropy, by the mass law as a movement and fusion of individual molecules 
or kinetically as a relation of dissociation (kd) and association (ka) rate constants, when the 
saturation of the interaction has not started (Figure 3). 
 
Figure 3. Thermodynamic, mass law-based, and kinetic viewpoint on the affinity of  
a ligand – analyte interaction. In the kinetic expression, the dissociation constant (KD; the 
reciprocal of the association constant KA) is the quotient of kd and ka are the dissociation and 
association rate constants of the interaction. For the thermodynamic expression of dissociation, 
G is Gibbs free energy, H is enthalpy, and S is entropy. T is the ambient temperature and R is 
the ideal gas constant. [L], [A], and [LA] denote the concentrations of ligand, analyte, and 
ligand-analyte complex, respectively. The figure was recreated based on the presentation of 
Martin Vogtherr, Ph.D. (AstraZeneca, currently in Merck). The presentation named “NMR to 
characterise protein-ligand interaction: Applications in drug discovery” was retrieved in August 
19, 2017. 
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The kinetic analysis can be performed in principle for the dataset that includes a series of analyte 
dilutions covering a range correlating with 0.1 and 10 times the KD value. The analyte dilutions 
are injected in a row with an expected dissociation time using air-bubble segmentation that 
prevents a diffusional dilution of sample with running buffer, and ensures the accurate 
concentrations of analyte molecules. Alternatively, when the dissociation rate constant (kd) is 
sufficiently small, one can inject analyte dilutions without the dissociation phase, and determine 
dissociation rate constant from the tail part left after the injections. (Schasfoort 2017)  
2.2 SPR biosensing 
Surface plasmon resonance (SPR) biosensing systems have been designed for numerous 
analytes, such as for the lead molecules of drug discovery (Cooper 2002), for human cancer 
biomarkers (Mariani and Minunni 2014), and for mycotoxins in the food industry  
(Li et al. 2012). The properties and the number of samples as well as the application area and 
the purpose of measurement set some requirements for the instrument and the sensing surface 
design. The deep understanding of these requirements is essential for the planning and 
optimization of the experiments. The next sections describe the essential theory behind the SPR 
phenomenon, present the structure of basic SPR instrumentation, and list some of the most 
common challenges faced by the SPR biosensors. 
2.2.1 Fundamental theory of the SPR phenomenon 
Surface plasmon resonance is defined in various ways in the literature, but essentially SPR is 
composed of propagating electron density waves called surface plasmons (SPs). SPs occur at 
the interface between a metal and a dielectric, where free electrons (signified by the negative 
dielectric constant of the metal) are able to oscillate under certain conditions (Couture et al. 
2013). More precisely, the excitation of SPR requires a functional combination of the optical 
and physical properties of the metal and the dielectric layers (RIs, dielectric constants, and 
thicknesses) as well as the right wavelength and polarization of laser light in addition to a 
suitable incident angle of laser light (Homola 2008). When the optical properties of the 
dielectric layer alter e.g. due to the biomolecule adsorption, the conditions where the 
propagating electron density wave is excited, change accordingly. The wavelength of laser light 
defines the propagation length of SPR from the gold surface that is sensitive to the optical 
changes. The incident laser light must be p-polarized because only p-polarized light can induce 
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SPs. The evanescent field of SPR is directed perpendicular to the interface between a metal and 
dielectric in both directions as shown in the inset of Figure 4.  
Figure 4. SPR detection system based on Kretschmann-Raether configuration. The presented 
parts from the MP-SPR Navi™ instrumentation cover the flow cell made of PDMS or PEEK 
polymers; the fluidic channel, which is formed when the flow channel cuvette is docked against 
the sensor slide; and the prism as well as the moving laser (or equivalent) and detector. The 
prism is in optical contact with the gold layer via index-matching elastomer (Kretschmann-
Raether configuration). The schematic inset demonstrates the reflection (arrow upwards) and 
refraction (arrow downwards) of incident p-polarized laser light at the interface between the 
glass substrate and the gold layer as well as the induced evanescent field of SPR (marked with 
red area). The shape of the illustrated evanescent field represents the exponentially decaying 
magnitude of SPR) (Schasfoort 2017). Analyte molecules are injected into a fluidic channel, 
where they move into and away from the adsorption layer by diffusion and convection. The 
figure is not in scale. 
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The field intensity of the evanescent field decays exponentially and it is stronger close to the 
dielectric than the metal. The sensitivity of the SPR detection is limited to the physical distance 
(commonly referred to as a penetration depth) determined by the decay length of the evanescent 
wave. In practice, the decay length of the evanescent wave corresponds roughly to one third of 
the laser wavelength used in the instrumentation. This usually covers the absorption layer of 
biomolecules (presented in the inset of Figure 4) and makes traditional SPR a surface-sensitive 
technique. 
The SPs can be excited in local and planar mode depending on the dimensions of the transducer 
material in relation to the wavelength of laser light. For example, nanoparticles (NPs) have 
significantly lower dimensions than the wavelength of laser light, which enables the excitation 
of strong, but not so far reaching SPs (Olaru et al. 2015). This phenomenon is commonly 
referred to localized SPR (LSPR). NPs can be utilized for instance in the amplification step of 
small molecule immunoassay. On a planar surface, the excitation of SPs is confined to a thin 
layer (semi-infinite) of the metal that provides a versatile platform for the integration of a fluidic 
system (Couture et al. 2013). 
Traditional planar SPR can be put into practice either with a Kretschmann-Raether or an Otto 
configuration. In the first option, the metal layer is in contact with the prism, and in the second 
option, there is a small gap between the prism and the metal layer (Schasfoort 2017). The Otto 
configuration provides a steeper profile of the SPR peak than the Kretschmann-Raether 
configuration, and therefore, it enables higher angular resolution to the SPR peak minimum 
angle shift. Due to practical challenges related to the docking of the sensor with a small gap, 
the Kretschmann-Raether configuration is a more popular approach at least among the 
commercial instruments (Couture et al. 2013). Therefore, later discussion regarding the SPR 
detection systems is limited to the planar Kretschmann-Raether configuration. 
2.2.2 MP-SPR instrumentation 
The Kretschmann configuration-based optical detection system of SPR with a flow cell cuvette-
based fluidic system (presented in Figure 4) includes a laser that emits p-polarized light at a 
convenient wavelength, a prism that couples the laser light on the gold surface of a sensor slide, 
and a detector that records the intensity of reflected laser light (Couture et al. 2013). In the 
optical setup of the MP-SPR Navi™ instrument manufactured by BioNavis Ltd  
(Tampere, Finland), the laser system and the detector are in a synchronized movement that 
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enables a broad angular scan of incident angles with corresponding intensity. The information-
rich measurement data can be plotted in a full SPR curve (presented in Figure 5). 
The sensor slide that is used as a transducer forms the interface for the electron oscillations of 
the SPR phenomenon described in the previous section. The standard gold sensor slide of MP-
SPR Navi™ instruments (BioNavis Ltd) comprises the following layers listed from the prism 
side to the sensing interface: (1) a glass substrate, (2) a thin adhesion layer, and  
(3) an approximately 50 nm thick “plasmonic” layer of planar gold as depicted in the inset of 
Figure 4. The glass substrate makes the sensor slide tougher. A thin adhesion layer is applied 
on the glass substrate to improve the quality of plasmonic metal deposition (Sexton et al. 2008). 
Silver has better properties for the SPR excitation, but poor inertness (Olaru et al. 2015). 
Therefore, the second-best metal, gold, is most often chosen for the plasmonic metal layer. 
During the docking of the flow cell cuvette, the glass prism is fixed in optical contact with the 
glass substrate of the sensor slide via an index-matching elastomer or oil. At the same time, the 
fluidic channels of the flow channel are formed against the gold surface of the sensor slide. 
The purpose of the flow cell is to direct the sample flow to the fluidic channel, where the analyte 
molecules move into and away from the adsorption layer by diffusion and convection. The flow 
cell is most often made of a polymeric material that shows chemical resistance and anti-fouling 
properties at some level. Polyether ether ketone (PEEK) and poly(dimethylsiloxane) (PDMS) 
polymers are commonly used flow cell materials (Schasfoort 2017). 
When the laser light hits the interface between two media (as in the inset of Figure 5), there are 
four possible outcomes: the light is reflected from the interface, refracted at the interface, or 
absorbed or scattered by the media (not shown for clarity). These phenomena occur mostly at 
the same time and they are dependent on the incident angle of light, the RIs and absorbance of 
the media as well as the surface topography of the interphase (Cooper 2002; Schasfoort 2017).  
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Figure 5. The full MP-SPR curve covering the SPR peak as well as the position of total internal 
reflection (TIR). The SPR peak minimum angle is the most utilized parameter, but the 
measurement of SPR peak minimum intensity (PMI) as well as the position of TIR enables the 
follow-up of optical scattering and absorbance properties of the dielectric layer as well as the 
compensation of bulk effects, respectively. The ratio of PMI and TIR intensity is described by 
Fresnell equations. The angle of TIR can be calculated using Snell’s law. The MP-SPR curve 
was exported from MP-SPR Navi™ DataViewer software (BioNavis). 
The MP-SPR Navi™ instruments measure a broad range of incident angles to monitor all the 
previously mentioned fates of laser light. At first the analyte molecules diffuse from the bulk 
phase to the adsorption layer. Then the interaction of the sensing surface-immobilized ligands 
with the analyte molecules changes the optical properties, such as the RI, near the sensing 
surface which induces a shift in the SPR peak minimum angle (denoted in Figure 5). Practically, 
the conversion of photons to plasmons can be seen as an intensity drop in the detector at a 
certain incident angle of laser light. There are a few instruments that follow shifts in the other 
optical parameters of the reflected light, such as phase (Huang et al. 2012), wavelength 
(Couture et al. 2013), and SPR peak minimum intensity (PMI) (Kurihara and Suzuki 2002) with 
pronounced benefits, but they have marginal commercial interest. For the same reason, these 
approaches are left outside this thesis. 
Some samples absorb or scatter the laser light, e.g. NPs, which is detected as an increase in the 
PMI (Viitala et al. 2013). In this context, the optical scattering and absorptivity mean that less 
photons of laser light are capable of exciting SPs, and this is detected as increase in PMI. Snell’s 
law provides the critical angle of total internal reflection (TIR) when the RIs of materials are 
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known (Couture et al. 2013; Schasfoort 2017). The TIR angle can be utilized to follow the 
beginning and the end of sample solution injection when the signal responses are small, as well 
as to compensate e.g. the buffer mismatch-caused bulk effect. Fresnel equations determine the 
ratio of refracted and reflected light, which can be applied when the thicknesses of multilayered 
structures are resolved (Nabok and Tsargorodskaya 2008). 
The main advantages of the SPR systems in biosensing applications are the non-invasive optical 
detection and the calibration-free concentration analysis that is based on the natural occurrence 
of RI changes, when the ligand molecules adsorb on the sensing surface (Helmerhorst et al. 
2012). 
2.2.3 Challenges in SPR biosensing 
Mass-transport-limited binding occurs when the diffusion of an analyte is slower than the 
association rate of the analyte on the sensing surface (Cooper 2002). It is characteristic 
especially for very large analytes (with low diffusion rates) as well as for the analytes showing 
extremely fast association kinetics (in comparison to the diffusion rate). MTL binding may also 
lead to the undesired re-binding of an analyte, which distorts the observed kinetics of the 
interaction (Papalia et al. 2006). In other words, the association and dissociation rates of the 
analyte molecule seem to be slower than they are in reality. MTL can be largely avoided by 
increasing the flow rate or lowering the ligand density on the sensing surface (Cooper 2002). 
In bioassays, where the concentration of an analyte is determined, the high ligand-density-
induced MTL is, however, exploited as this makes the analyte binding process mass-transport-
dependent, and less dependent on the ligand – analyte kinetics. The use of the MTL factor in 
the kinetic calculations is not recommended (only with troubled cases).  
The RIs of buffers and sample materials are slightly temperature-dependent, which makes SPR 
detection systems susceptible to temperature-induced signal drift. This issue is handled with an 
accurate temperature controller that can efficiently increase and lower the flow cell temperature 
as well as with a parallel reference channel. The signal drifts and bulk effects originating from 
the swelling of a hydrogel matrix, or from the variation in mass distribution after ligand 
immobilization affect the quality of the measurement data. They can be treated with an extended 
stabilization time of the hydrogel matrix in the running buffer as well as with a proper reference 
channel subtraction. (Cooper 2002) 
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Small MW analytes are regularly prepared and stored in 1-10 % dimethyl sulfoxide (DMSO), 
a highly polar solvent that is a gold standard for the solubility enhancement in the lead molecule 
generation of drug discovery. In the case of hydrogel matrices, the use of DMSO may, however, 
cause a bulk effect that masks the specific binding signal of an analyte (Cooper 2002). When 
the ligand molecules are immobilized into the hydrogel matrix, variation in the hydrogel void 
volume (i.e. the volume occupied by macromolecules and not available for the analyte 
molecules) arises between the active and reference channel. One way to circumvent this 
problem (sometimes called the excluded volume effect) is to create a calibration curve for the 
suitable range of DMSO concentration in running buffer without the analyte molecules 
(Frostell-Karlsson et al. 2000). This treatment ‘normalizes’ the bulk RI changes observed in the 
different flow cells. 
Finally, the air bubble management is crucial for the success and reliability of the ligand 
immobilization and subsequent experiments with an analyte. Air bubbles prevent molecules 
from adsorbing and they may cause long-lasting displacements in the signal response if they 
remain on the surface (BiacoreTM Assay Handbook 2012). The buildup and movement of air 
bubbles on the sensing surface increase the light scattering and change the RI of the sample 
solution, respectively (Vallée et al. 2005). Practically, these processes can be monitored as an 
increase in the PMI signal and as spikes in the SPR peak minimum angle signal, respectively, 
to assess the reliability of measurement results (BiacoreTM Assay Handbook 2012). The 
formation of air bubbles can be reduced by degassing the buffers and samples by sonication in 
an ultrasonic water bath as well as stirring under vacuum. 
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3 OBJECTIVES 
The two primary aims of this thesis were to adapt the protocols introduced by Zauner and 
collaborators in 2016 to a two-channel MP-SPR instrument manufactured by BioNavis Ltd, and 
to assess the performance of the regenerable biosensing system. In addition, it was interesting 
to explore if the real-time measurement of the full SPR curve and the TIR angle and intensity 
would reveal something new about the binding event of multivalent proteins.  
The secondary aim was to evaluate how a four-channel MP-SPR prototype of BioNavis 
company adjusts to the challenges commonly faced by the optical techniques when rapid 
association kinetics of small MW drugs are measured in an angular scan mode. The broadly 
cited article of Papalia et al. 2006 was selected as a reference article, owing to the comparable 
instrumentation (a four-channel Biacore™ 3000 SPR instrument from GE Healthcare) and the 
well-documented protocol that can be applied to the instrument testing of kinetic limits. The 
human carbonic anhydrase II (hCAII) enzyme was selected instead of bovine carbonic 
anhydrase II for the experiments as this resembles more closely the pharmacodynamics of 
human-targeted drugs. 
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4 MATERIALS AND METHODS 
4.1 Immunosensing platform with stepwise regeneration 
4.1.1 Materials 
The running buffer, phosphate buffered saline (PBS) pH 7.30 containing 1.8 mM KH2PO4, 
10 mM Na2HPO4, 140 mM NaCl, and 2.7 mM KCl was prepared by dissolving corresponding 
amounts of salts in deionized water (approx. 18.2 MΩ cm) and adjusting the pH of the running 
buffer with concentrated HCl. All the buffer components were purchased from Merck 
(Darmstadt, Germany). At the end, the running buffer was filtered through a sterile Nalgene® 
bottle-top filter (pore size 0.45 μm; Sigma-Aldrich, Saint Louis, MO, USA), autoclaved 
in-house, and stored at +4 °C for few weeks at maximum. 
The b-SAM was deposited on the gold surface of a standard MP-SPR Navi™ sensor slide 
(BioNavis) with some changes to the original protocol described elsewhere (Pollheimer et al. 
2013. Supporting Information p. 19 - 22). The b-SAM membrane was prepared from matrix 
alkanethiols, MAT (HS-C11-(EG)3-OH; MW = 336.53 g mol-1; ProChimia Surfaces) and 
biotin-terminated alkanethiols, BAT (HS-C11-(EG)6-Biotin; MW = 694 g mol-1; ProChimia 
Surfaces, Sopot, Poland) by Martin Albers from BioNavis company. Briefly, chloroform 
dissolved MAT and BAT were mixed at a molar ratio of 80/20 to gain the desired biotin content 
of b-SAM surface. Prior the deposition, the gold sensor slides were cleaned with boiling 
ammonium peroxide solution (deionized water, 30 % hydrogen peroxide and 30 % ammonium 
hydroxide at volumetric fractions 5/1/1, respectively) for 3 minutes and rinsed multiple times 
with deionized water and 95.5 wt% ethanol (Altia Industrial, Rajamäki, Finland). Sensor slides 
were placed in Petri dishes with 10 mL ethanol and 0.5 mL of the mixture was applied into 
ethanol by pipetting with gentle mixing done with the tip. The Petri dishes were enclosed with 
aluminum foil to prevent the evaporation of ethanol. After overnight deposition at room 
temperature (RT), the sensor slides were washed with ethanol and dried with nitrogen gas. The 
sensor slides were stored at +4 °C and before use they were stabilized at 20 µl min-1 running 
buffer flow. It was possible to re-use the sensor slides after the experiments for some weeks. 
The fully regenerated sensor slides were rinsed multiple times with deionized water, blown dry 
with compressed air, and stored at +4 °C. 
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The protein solutions were used as received and diluted directly in the running buffer or the 
sample buffer. The protein concentrations of immobilization solutions were confirmed at 
280 nm wavelength by a NanoDrop 2000 ultraviolet – visible light (UV-Vis) spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA, USA). The purity of proteins was assessed based on 
the absorbance ratio A280/260 in addition to the information reported in the certificate of 
analysis or the specification of the protein sample. The salt or preservative residuals of 
lyophilized proteins or protein stock solutions were ignored in the protein concentration 
determination, and prospective bulk effects were accepted due to the low concentrations. 
The immobilization solution of switchavidin was prepared from a lyophilized and -20 ºC stored 
protein aliquot that was produced, purified, and characterized by Niklas Kähkönen from the 
Protein Dynamics research group. The theoretical MW of tetrameric switchavidin is 57.2 kDa 
(Taskinen et al. 2014. Figure S2). The optical extinction coefficient, κ (i.e. how much light at 
a given wavelength is absorbed into a protein solution of a given concentration) had been 
calculated earlier at 280 nm in water using a ProtParam tool (Gasteiger et al. 2005) resulting in 
23615 M-1 cm-1 (http://biomeditech.fi/Protein_Shop/switchavidin.html; March 24, 2017). The 
integrity and purity of non-protein contaminants had been tested with a SDS-PAGE method 
and an UV-Vis spectrophotometer. 
The net surface charge of switchavidin had been neutralized by genetic engineering to improve 
the anti-fouling feature against counter-charged molecules (Taskinen et al. 2014). In detail, 
three neutralizing mutations (K9E, R124H, and K127E) that do not interfere with the ligand 
binding or structural integrity of the tetramer had been designed and introduced to a 
M96H/R114L mutant form of avidin that show improved affinity towards the conjugated biotin 
and controlled regeneration of biotin-avidin-biotin bridges (Taskinen et al. 2014). The resulting 
isoelectric point (pI) of switchavidin is 7.02. 
Lysozyme enzyme (from chicken egg white; dialyzed) and bovine serum albumin (BSA; heat 
shock fraction; ≥ 98 %) were purchased in the form of lyophilized powder from Sigma-Aldrich. 
The whole IgG purified from normal human serum (h-IgG) by affinity immunoelectrophoresis 
was purchased in a storage buffer from Jackson ImmunoResearch (West Grove, PA, USA). 
The (biotinylated) immunoglobulin-binding protein originally expressed in Streptococci 
(group G) and now termed “biotinylated protein G” was utilized as a mediator to immobilize 
IgG molecules on the switchavidin layer. The truncated form of the (biotinylated) protein G 
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lacking the Fab and albumin binding sites, and the membrane-binding regions was purchased 
in the form of lyophilized powder (≥ 98 % by Biuret assay) from Sigma-Aldrich. A single 
protein G molecule had been biotinylated with three biotin residues on average according to the 
certificate of analysis. 
The sensing platform was biofunctionalized using monoclonal human prostate-specific antigen 
(PSA) targeting IgG antibodies (anti-PSA; ≥ 95 %; Medix Biochemica, Espoo, Finland).  
The dilution series of anti-PSA (nominally 200 nM, 100 nM, 67 nM, etc. down to 0.02 nM) 
were prepared from a 670-nM stock solution with sample buffer that was running buffer with 
additional 1 µM of BSA (Sigma-Aldrich). 
The solution used for normal regeneration was prepared by dissolving 100 mM glycine 
(≥ 98 %; VWR International, Radnor, PA, USA) in deionized water and adjusting pH to 2.7. 
The solution for rigorous regeneration was prepared by dissolving 0.25 % of sodium dodecyl 
sulfate (SDS, 99.8 %; VWR International) in deionized water, adding 2.5 % citric acid (99.7 %; 
VWR International) and adjusting pH to 2.0. The simple washing solution for protein residuals 
was prepared by dissolving 0.5 % of SDS (VWR International) in deionized water. 
4.1.2 SPR experiments 
The SPR measurements were performed using MP-SPR Navi™ 210A VASA instrument 
(BioNavis) equipped with a standard PEEK flow cell that forms two fluidic channels over the 
sensor surface. The samples were loaded into the fluidic system of the instrument from preset 
vials with autosampler-controlled air-bubble segmentation to ensure accurate concentration of 
sample molecules. The SPR data was recorded simultaneously from the measurement spots of 
two flow channels, which were covered with differing protein assemblies depending on the 
experiment. The SPR instrumentation contained four lasers measuring at two different 
wavelengths (670 nm and 785 nm) in each flow channel. The running buffer and reagents were 
equilibrated at RT approximately for 15 minutes (some millilitres) to one hour (hundreds of 
millilitres), and degassed before use by tapping the liquid filled plastic syringe under negative 
pressure. All the measurements were performed at 25 ºC using a 20 µL min-1 flow rate unless 
otherwise noted. 
The regeneration of sensor slides was performed by removing the switchavidin layer and the 
proteins bound on top of it (termed as “rigorous regeneration”) with a 12-min injection of 2.5 % 
citric acid (pH 2.0) and 0.25 % SDS. The subunits of switchavidin dissociate and denature, and 
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after the removal of tiny protein remnants by an 8-min injection of 0.5 % of SDS, the sensor 
slide is ready for the new cycle (Pollheimer et al. 2013).  
Stability of the instrument and b-SAM 
Prior the SPR experiments, the running buffer was filtered through a Millex®-VV sterile 
syringe filter (Merck Millipore, Billerica, MA, USA), which was equipped with a 0.1 µm pore 
sized hydrophilic PVDF membrane to sterilize aqueous solutions. At the beginning of the 
experiments, the flow cell was primed with b-SAM deposited gold sensor and filled with the 
running buffer using 100 µL min-1 flow rate. This was verified by a single angular scan of the 
SPR peak minimum as air bubbles can be detected as peaks in the region of 42 – 45 degrees. 
Then, the injection system was cleaned with two 5-min injections of 1% Hellmanex III 
(Hellma Analytics, Müllheim, Germany) with short buffer injections between. In the next step, 
a full SPR curve was measured at 20 µL min-1 flow rate exceptionally at +20 °C. The 
subsequent measurements were performed with higher flow cell temperature (+25 °C) than 
ambient temperature in order to reduce air bubble formation. The baseline drift was calculated 
manually from the linear regression of a 30-minute time period. The additional requirements 
were the stabilized flow cell temperature and PMI signal that indicates the buildup of air. 
Randomly occurring peaks with the magnitude higher than the noise level times two (illustrated 
in Figure 6) were excluded from the signal analysis. The definition of randomly occurring 
negligible peaks is based on the assumption that two standard deviations of the signal cover 
95.5 % of random variation (~ i.e. noise) in the signal (Armbruster and Pry 2008). The average 
drift and sample standard deviations were reported separately for the upper and lower flow 
channel. 
 
Figure 6. A schematic illustration of noise, drift, and a peak with magnitude higher than the 
noise level times two. The figure was recreated based on the illustration presented at 
http://hplc.chem.shu.edu/NEW/HPLC_Book/Detectors/det_nise.html in August 22, 2017. 
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Switchavidin immobilization on the biotinylated gold surface 
Switchavidin was immobilized on the biotinylated gold surface at 2 µM concentration by  
a 10-min parallel or serial injection. The switchavidin immobilization solution was degassed 
under vacuum before the injection to minimize air bubble formation. The arithmetic mean of 
switchavidin immobilization levels was reported with sample standard deviations (SD). 
Anti-fouling ability of the switchavidin surface 
The anti-fouling ability of the switchavidin layer and the hydrophilic b-SAM surface was 
evaluated against BSA, lysozyme and human immunoglobulin G (h-IgG) molecules that were 
introduced at a concentration of 1 mg mL-1 individually for 5 minutes. The fouling levels of 
double BSA-blocked and non-blocked switchavidin layers were recorded from separate flow 
channels, and compared to assess the efficiency of BSA blocking. The response level of the 
second BSA injection was compared with the fouling level of the first BSA injection to 
determine the completeness of BSA blocking process. 
Biofunctionalization of biotinylated protein G layer with anti-PSA  
At first, the reference flow channel was passivated with a 3-min injection of 2 µM biotinylated 
BSA (biotinylated by Barbara Taskinen approximately with three biotin residues per protein 
molecule) to reduce the non-specific binding of anti-PSA and BSA molecules. Then, 
biotinylated protein G molecules were injected on the switchavidin layer of an active flow 
channel at a concentration of 2 µM for 5 minutes to construct a sensing platform that orients 
anti-PSA molecules perpendicularly to the sensing surface with regenerable interaction. Lastly, 
both of the flow cells were passivated once again with a 5-min injection of 2 µM biotinylated 
BSA and blocked with a 5-min injection of 1 mg mL-1 BSA in order to minimize the fouling of 
anti-PSA and BSA molecules. 
The dilution series were injected in serial mode from the highest concentration, 200 nM 
(~ 100*KD) to the lowest concentration, 20 pM (~ 0.01*KD) primarily to resolve kinetics and 
affinity between the Fc-fragment of anti-PSA and the IgG-binding domains of protein G 
molecules. Secondary aim was to reach the ligand saturation point i.e. the highest 
immobilization level possible. The reference KD value used for the calculations of dilutions was 
2 nM (Zauner et al. 2016). The association time i.e. injection time was 5 minutes for the  
20 – 200 nM dilution range of anti-PSA and 10 minutes for the rest of the dilutions. The 
dissociation time i.e. post-injection time was 9 minutes. 
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The selective removal of the interactions between the Fc-fragment of anti-PSA and the IgG-
binding domains of protein G molecules (termed as “normal regeneration”) was performed 
between the anti-PSA injections by a single 5.5-min injection of 100 mM glycine (pH 2.7) 
(Zauner et al. 2016). A small fraction of switchavidin desorbed expectedly from the biotinylated 
surface during the first normal regeneration injection and therefore, an extra-injection of 
200 nM anti-PSA and a single “dummy” injection of glycine solution was performed prior to 
the true dilution series. This resulted in a relatively steady baseline within the statistical 
variation.  
4.1.3 Data analysis and kinetic fitting 
The statistical analysis of switchavidin immobilization levels was performed using SPSS 
Statistics software for Windows, version 23 (IBM Corp., Armonk, N.Y., USA). 
The kinetic analysis for the biotinylated protein G – anti-PSA interaction was performed using 
MP-SPR Navi™ DataViewer software, version 4.2.5 (BioNavis) and TraceDrawer™ software, 
version 1.7 (Ridgeview Instruments, Uppsala, Sweden). The angular position of the SPR peak 
minimum was determined using an algorithm (called Weighted Centroid) that weights the 
angular data points near the peak minimum with the corresponding intensity values (Johansen 
et al. 2000). This algorithm takes the non-symmetrical shape of the SPR peak minimum into 
account, provides a high signal-to-noise ratio of the SPR signal, and is also less sensitive to air 
bubble-induced noise. 
The data processing steps of sensorgram data are illustrated in Figure 7 with schematic pictures. 
The signals coming from the active and reference flow channel were firstly auto-offsetted 
regarding the y-axis (intensity) to set a joint baseline level. This facilitated the second step, 
where the x-axis (time) was offsetted to correct the delay time between the flow cells. In the 
third step, the SPR signals coming from the active biotinylated protein G coated flow channel 
were referenced against the biotinylated BSA passivated flow channels. 
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Figure 7. The data processing of sensorgram data. In the first step, the kinetic curves recorded 
from the active and reference flow channel were auto-offsetted regarding the y-axis (intensity) 
to make it easier to correct the dead volumes between the flow channels in the second step. The 
referencing of sensorgram data was performed in the third step, where the signal coming from 
the reference flow channel was subtracted from the signal coming from the active channel. 
In the third step, the starting and ending points of the anti-PSA injections were defined based 
on the visible association and dissociation phases in respect to the programmed length of the 
anti-PSA injections. The length of the baseline was set to 5 minutes and the tail parts were set 
as long as possible. 
The advanced kinetic analysis was started by exporting the kinetic curves to TraceDrawer™ 
software, version 1.7 (Ridgeview Instruments), and typing the accurate anti-PSA concentrations 
for the individual curves, which were calculated from the concentration of stock solution.  
The signal spikes originating from the numerous reasons rationalized in section 2.2 were cut 
from the curves to improve the kinetic fitting. The plotted kinetic data was scaled from angular 
degrees to millidegrees (mDeg) in order to improve the calculation of kinetic values. 
Finally, the kinetic data was fitted to Langmuir and bivalent adsorption models, which 
correspondingly describe 1:1 and 1:2 binding stoichiometries. The Langmuir fitting is 
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commonly presented beside bivalent fitting for comparability of kinetic values, but the observed 
binding rates are empirical and do not reflect the mechanical binding model. The bulk signal 
was set to zero, and all the other variables were set as global i.e. to be calculated similarly for 
all the curves. The resulting kinetic and affinity values with the errors, Chi2, and fitting residuals 
were reported. 
4.2 Interaction kinetics of sulfonamide hCAII inhibitors 
4.2.1 Materials 
The PBS buffer containing 10 mM phosphate (pH 7.4 at +25 ºC), 137 mM sodium chloride, 
and 3.7 mM potassium chloride, was prepared by dissolving a single PBS tablet (Sigma-
Aldrich) in 200 mL of deionized water. 
The standard MP-SPR Navi™ gold sensor slides (as described in section 4.1.1 above) with 
a 500-nm thick three-dimensional low-density carboxymethylated dextran coating 
(type CMD 500L) were purchased from XanTec (Düsseldorf, Germany). 
The stock solution of a human carbonic anhydrase II (hCAII) enzyme, which was received as 
a donation from the Tissue Biology research group of professor Seppo Parkkila (Faculty of 
Medicine and Life Sciences, the University of Tampere), contained 0.1 M Tris-SO4, 
0.4 M NaN3, 1 mM benzamidine, and 20 % glycerol. According to the amine coupling kit 
instructions of Thermo Fisher Scientific, all the previously listed additives interfere with the 
non-specific EDC/NHS amine coupling chemistry. The interfering additives were removed 
from the protein aliquots by a five-fold ultrafiltration through a Vivaspin® 500 10,000 MWCO 
PES membrane equipped ultrafiltration device (Sartorius AG, Göttingen, Germany) roughly as 
described in the user manual of the manufacturer. The MWCO is an abbreviation for the 
molecular weight cutoff, and it designates the lowest limit for the size of molecule that can be 
retained in the sample solution during the washing steps. A one size smaller MWCO of  
PES membrane than recommended for 29 kDa proteins was chosen based on the experience 
obtained in previous projects (Jenni Leppiniemi, Ph.D., personal communication). This ensures 
better recovery of the hCAII enzyme. 
The immobilization solution of hCAII was prepared in a 10 mM MES buffer, pH 5.70 (2-(N-
morpholino)ethanesulfonic acid; Sigma-Aldrich) at a concentration of 0.25 mg mL-1.  
 30 
The suitable pH for the immobilization solution of the human CAII was estimated to be 
0.5 - 1 pH units below the theoretical isoelectric point of the hCAII (pI = 6.86) based on the 
standard operation procedure commonly used for the EDC/NHS amine coupling chemistry 
(Fischer 2010). The theoretical isoelectric point of the hCAII was calculated at 280 nm in water 
using a ProtParam tool (Gasteiger et al. 2005) with Swiss-Prot/TrEMBL accession number 
P00918 (PDB ID: 3HS4. Sippel et al. 2009). EDC (MW = 191.70 g mol-1) and NHS 
(MW = 115.09 g mol-1) reagents were purchased from Sigma-Aldrich. The selected pH of the 
immobilization solution was validated in further studies based on the steepness and the 
curvature of the pre-concentration injection responses. In the pre-concentration testing, the 
enzyme is absorbed into the CMD hydrogel matrix via electrostatic attraction at  
different pH conditions, which creates varying local enzyme concentrations 
(https://www.sprpages.nl/immobilization/ligand-pre-concentration; August 22, 2017). The 
equilibration of the hydrogel matrix and the blocking of the unreacted NHS-ester groups were 
performed using 0.1 M Na-borate buffer (pH 9.0) with 1 M NaCl, and 1 M ethanolamine 
(pH 8.5), respectively. These reagents were purchased from Xantec. 
Three sulfonamide-based inhibitors of hCAII (acetazolamide, AZE; methanesulfonamide, 
MSU; 4-sulfamoylbenzoic acid, 4-CBS) were purchased from Sigma-Aldrich for the 
experiments, in which the interaction kinetics of hCAII with the inhibitors was resolved. The 
stock solutions of MSU, AZE, and 4-CBS were prepared in PBS buffer containing DMSO 
(Sigma-Aldrich) solvent or alternatively in pure DMSO. The 20-mM stock solution of the 
smallest inhibitor, MSU (MW = 95.12 g mol-1), was prepared directly in 3 % (v/v) DMSO 
solvent containing PBS buffer based on the knowledge of a supervisor. The complete 
dissolution of larger, AZE (MW = 222.25 g mol-1) and 4-CBS (MW = 201.20 g mol-1), 
inhibitors required the use of pure DMSO as an intermediate step. In all cases, a slightly smaller 
quantity than needed for 20 mM inhibitor solution was weighed. Then, the corresponding 
volume of PBS with 3 % DMSO (density ≈ 1.00 g mL-1) or pure DMSO (density = 1.10 g mL-1) 
was added accurately with the aid of an analytical balance (Sauter analytical balance,  
type RE 1612, reproducibility 1 mg; Sauter, Balingen, Germany). The weighed volumes 
enabled the accurate calculation of inhibitor concentration for the stock solutions. Then, the 
corresponding 0.1*KD – 10*KD dilution series were prepared using PBS without or with 
3 % (v/v) DMSO (Davidoff et al. 2015). For example, the concentration range of AZE, which 
extended from 3 nM to 200 nM was prepared by serial two-fold dilutions of the inhibitor stock 
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solution. A careful preparation of the dilutions series concerning the buffer mismatch has great 
importance as this may cause problematic bulk effects in the SPR signal.  
4.2.2 SPR experiments 
The interaction kinetics of hCAII with the inhibitors were measured using the prototype of 
420A ILVES MP-SPR Navi™ instrument (BioNavis) equipped with a standard PDMS flow 
cell that forms four fluidic channels over the sensor surface. The injectables were loaded into 
the fluidic system of the instrument from a 96-well plate with autosampler-controlled air-bubble 
segmentation that ensures accurate concentration of sample molecules. The SPR data was 
recorded with a single wavelength (670 nm) from two enzyme-activated (FC2 and FC4) and 
two reference channels (FC1 and FC3).  
The flow cell temperature was stabilized at an experiment temperature of +25 ºC. The running 
buffer, protein solutions, and reagents were stabilized at RT and degassed by tapping the liquid 
filled plastic syringe under negative pressure. The hydrogel matrix of CMD 500L sensor slides 
was rehydrated and stabilized at the experiment flow rate prior to use until the SPR signal drift 
was minimal, and a stable baseline was achieved. All the experiments were performed using  
a flow rate of 20 µL min-1 with the exception of the gas removal from the fluidic system, which 
was performed using a 200 µL min-1 flow rate.  
Immobilization of hCAII into 3D hydrogel matrix 
The hCAII enzyme was immobilized into the hydrogel matrix of a CMD 500L sensor slide 
using the EDC/NHS amine coupling chemistry. The immobilization was performed in PBS 
buffer by following the protocol described in the article of Papalia and colleagues in 2006 with 
minor modifications. At first, the hydrogel matrix was equilibrated for 7 minutes with a 1 M 
NaCl, 0.1 M sodium borate buffer (pH 9.0) injection that balances the electrostatic interactions 
of the matrix. Secondly, the carboxyl groups of the hydrogel matrix were activated with a 
7-minute injection of freshly prepared 0.4 M (76.7 mg mL-1) EDC / 0.1 M (11.5 mg mL-1) NHS 
mixture in deionized water that was degassed carefully right before the immobilization solution 
was loaded into the sample loop. After a 10-minute rinsing step, the immobilization solution of 
hCAII was introduced on the surfaces of the active flow channels (FC2 and FC4) for 
10 minutes. At the end, the unreacted NHS ester groups were blocked simultaneously from all 
the hydrogel matrices of the flow channels (FC1 – FC4) by a 10-minute injection of  
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1 M ethanolamine (pH 8.5). The alkalinity of the blocking solution removed also the 
physisorbed hCAII from the hydrogel matrix. 
Interaction kinetics of hCAII with inhibitors 
The interaction kinetics of hCAII with the inhibitors was measured at +25 ºC with the highest 
data collection frequency. PBS with 3% DMSO was used as an immobilization buffer. At the 
beginning of the dilution series, two blank injections of the running buffer were added to test 
the stability of the enzyme-immobilized matrices. Then the inhibitor dilutions were injected in 
serial mode for 4.5 minutes from the lowest to the highest concentration with a 6-minute delay 
time (dissociation phase) between the injections. 
4.2.3 Data analysis and kinetic fitting 
The kinetic analysis for the interactions between hCAII and sulfonamide inhibitors was 
performed using MP-SPR Navi™ DataViewer (BioNavis) and TraceDrawer™ (version 1.8; 
Ridgeview Instruments). The SPR data was recorded from two active (FC2 and FC4) and two 
reference channels (FC1 and FC3). The angular position of SPR peak minimum was determined 
using the Weighted Centroid algorithm (Johansen et al. 2000). This increases the signal-to-
noise ratio, which is beneficial especially in small MW analyte detection. 
The data processing steps of sensorgram data were illustrated earlier in Figure 7 in section 4.1.3 
with schematic pictures. Firstly, the SPR peak minimum signals coming from the active and 
reference flow channel were auto-offsetted to a joint baseline level. This facilitated the second 
step, where the x-axis (time) was offsetted to correct the dead volumes between the flow cells. 
In the third step, the SPR signals coming from the active hCAII enzyme-immobilized flow 
channels (FC2 and FC3) were referenced against the non-modified flow channels (FC3 and 
FC4), respectively. 
The start and end points of the inhibitor injections were defined based on the visible association 
and dissociation phases in respect of the programmed lengths of the inhibitor injections. The 
length of the baseline was set as constant and the tail part was set as long as possible. 
The advanced kinetic analysis was started by exporting the kinetic curves to TraceDrawer™ 
software and entering the accurate inhibitor concentrations for the individual curves, which 
were calculated from the concentration of the stock solution. The signal spikes were cut from 
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the curves to improve the kinetic fitting. The plotted kinetic data was scaled from degrees to 
mDeg in order to improve the calculation of kinetic values. 
The dissociation rate constant was determined and set as constant before the kinetic data was 
fitted globally in a Langmuir adsorption model, which describes 1:1 binding stoichiometry 
where one inhibitor molecule binds one enzyme molecule at a time. The bulk signal was set to 
zero. The resulting kinetic and affinity values with the errors, Chi2, and fitting residuals were 
reported. 
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5 RESULTS 
5.1 Immunosensing platform with stepwise regeneration 
The SPR signal measured at 785 nm laser wavelength showed low combined drift for the 
instrument and the b-SAM surface. The immobilization levels of switchavidin were repeatable 
and reproducible, the switchavidin layer pointed out clear ultra-low fouling ability against 
common model proteins, and the two-step regeneration of the sensing platform shows practical 
resolution between two regeneration solution compositions. Furthermore, some observations 
concerning MP-SPR detection of the multivalent binding mechanism of switchavidin to b-SAM 
surface are presented. Based on the results presented in this chapter, the tentative diagnostic 
performance of the sensing platform is determined later in the discussion chapter. 
5.1.1 Stability of the instrument and b-SAM 
To assess the combined stability of the instrument and b-SAM on a gold sensor slide, the 
baseline drift of the SPR peak minimum angle was analyzed for a 30-minute time period at 
stabilized temperature and buffer flow conditions. The results listed in Table 1 were obtained 
from two parallel flow cells of three randomly chosen sensors. The baseline drift was reported 
at two wavelengths in mDeg min-1 with corresponding sample standard deviations. 
Table 1. Baseline drift of SPR peak minimum angle. The drift values were measured for three 
sensors in mDeg min-1 at two laser wavelengths (670 nm and 785 nm). Flow channel and laser 
wavelength –specific means and sample standard deviation (SD) were reported. 
  Baseline drift (mDeg min-1)   
 Wavelength (nm) Sensor #1 Sensor #2 Sensor #3 Meana SDa 
Upper 
FCb 
670 +0.22 +0.06 +0.14 +0.14 ±0.08 
785 +0.20 +0.05 +0.11 +0.12 ±0.08 
Lower 
FCb 
670 +0.42 +0.08 +0.18 +0.23 ±0.17 
785 +0.32 +0.06 +0.11 +0.16 ±0.14 
a Calculated in mDeg min-1 
b FC is an abbreviation for the “flow channel” 
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The calculated values for the baseline drift were smaller for the upper flow channel than for the 
lower flow channel at both wavelengths. The direction of the baseline drift was upwards in all 
cases. The sample standard deviations were smaller for the upper flow channel than for the 
lower flow channel. 
5.1.2 Immobilization levels of switchavidin 
The immobilization solution of switchavidin was assessed free from nucleic acid contaminants 
based on the 260/280 nm absorbance ratios, which were close to 0.57 (Raynal et al. 2014). The 
switchavidin immobilization levels on the b-SAM were analyzed from eight sensor slides with 
at least two repeats per each sensor (N = 25) (shown in Figure 8). The values presented in the 
graphs are reported only at laser wavelength 785 nm for directional comparability to values 
measured in the reference article at laser wavelength 760 nm of the Biacore® instruments. 
 
Figure 8. Sensor-specific immobilization levels of switchavidin in mDeg. The upper and lower 
channel of the flow cell are denoted with grey and red circles, respectively. The cycle numbers 
are shown together with the data points. First switchavidin injection to the lower flow channel 
of the sensor #1 was excluded from the dataset due to drift in the SPR signal. 
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The variables were qualified as approximately normally distributed based on the skewness 
values calculated by SPSS software. A small number of repeats, however, justified only the use 
of non-parametric tests in the statistical analysis. The arithmetic mean of switchavidin 
immobilization levels calculated from the sensor-specific averages for the upper and lower flow 
channels were 210.2 (SD 7.9) mDeg and 212.2 (SD 8.9) mDeg, respectively. The sample 
standard deviations correspond to less than 4.5 % variation in the immobilization levels. 
Independent-Samples Kruskal-Wallis test showed statistical difference between different 
sensors (p = 0.022 < 0.050). The comparison of flow cell-specific values by Wilcoxon test 
instead did not show a statistically significant difference between the flow cells 
(p = 0.093 > 0.050). 
The scatter plot of sensor-grouped switchavidin immobilization levels presented in Figure 9 
shows a decreasing trend between the cycles. Switchavidin injections affected by regeneration-
solution-induced drift were treated as outliers in the statistical analysis. Notably, the statistical 
analysis of switchavidin immobilization levels between the two flow cells was found to be 
sensitive to the existence of outliers in the analyzed dataset. When a single outlier was left in 
the dataset, the straightforwardly used paired T-test resulted in p-value of 0.049, which 
technically indicates statistically significant difference (p < 0.050) between the flow cell-
specified immobilization levels. The exclusion of the concerned outlier resulted in p-value of 
0.093 so there was no statistically significant relationship (p > 0.050) between the variables 
under the restrictions of the dataset. 
 37 
 
Figure 9. Immobilization levels of switchavidin at different cycles in mDeg. Sensor-specific 
values are presented in separate rows. The immobilization levels of the upper and lower flow 
channel are marked with grey and red circles, respectively. First switchavidin injection to the 
lower flow channel of the sensor #1 was excluded from the dataset due to drift in the SPR 
signal. 
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5.1.3 Mechanical binding model of switchavidin molecules 
The adsorption of (strept)avidin molecules on the planar biotinylated surfaces involves specific 
binding mostly via one or two biotin-(strept)avidin bridges as well as non-specific interactions 
among adsorbing proteins (cohesion) or between protein and immobilization surface (adhesion) 
(Dubacheva et al. 2017). These simultaneously occurring processes are, however, extremely 
difficult to model and verify. This section presents transient peaks, logarithmic decreases, and 
elevations observed in PMI signal, which support the later discussion of the mechanical 
adsorption model proposed of switchavidin on the b-SAM membrane. 
A transient peak and following logarithmic decrease and elevation in PMI data after the 
beginning of switchavidin adsorption were monitored in order to track changes in protein 
orientation or conformation leading to fluctuations in the surface area per molecule. Figure 10 
presents corresponding data from a single sensor slide for three experiment cycles.  
The transient peak seen in the first experiment cycle was higher than the subsequent peaks of 
the second and third experiment cycle. The elevation of the first cycle seemed to come earlier 
than the elevations seen for the second and third cycle. 
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Figure 10. A compilation picture of transient peaks and elevations observed in the SPR peak 
minimum intensity (PMI) signal from three cycles of switchavidin adsorption. The adsorption 
of switchavidin starts from zero minutes. The amplitudes and the time points of transient peaks 
are pointed with grey dashed lines. The grey arrows denote the positions of signal elevations. 
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5.1.4 Regeneration of immunosensing platform 
The first two baseline shifts after the first normal regeneration cycle (i.e. “dummy” injection) 
were roughly -5 mDeg, which corresponds to 2.4 % of mean adsorbed switchavidin 
(~211 mDeg), but later the baseline shift settled to -2 mDeg (0.9 %). Unfortunately, there was 
only a single sensor slide available for analyzing these baseline shifts. 
The baseline shifts after the first rigorous regeneration of the switchavidin layer by the 
combination of citric acid and SDS resulted in varying amounts of residual switchavidin or 
slight deterioration of the b-SAM. Later rigorous regeneration cycles showed more stable 
baseline shift, which was +3.7 mDeg for the upper flow channel, and corresponds to 1.8 % of 
mean adsorbed switchavidin (~211 mDeg). Related measurement data shown in Figure 11 was 
collected from various experiments with different protein compositions on top of the 
switchavidin layer, which means that obtained values for the baseline shift are unqualified to 
predict statistical behavior. However, a tentative analysis of trends can be deduced within a 
sensor. 
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Figure 11. The baseline shift after a rigorous regeneration treatment in mDeg. Sensor-specific 
values are categorized in separate columns. The immobilization levels of the upper and lower 
flow channel are marked with grey and red circles, respectively. The identical values for two 
cycles were fortified with black circle. The baseline shift values recorded from the lower flow 
channel of sensor #1 and #2 were removed from the dataset due to drift in the SPR signal. 
Relative regeneration efficiency (shown in Figure 12) was calculated for the rigorous 
regeneration with eight sensors from the immobilization levels of switchavidin (presented in 
Figure 8) and corresponding baseline shift values obtained after rigorous regeneration treatment 
(presented in Figure 11). 
 42 
 
 
Figure 12. The relative regeneration efficiency of rigorous regeneration in respect of the cycle. 
Sensor-specific values are presented in separate rows. The upper and lower flow channel are 
marked with grey and red circles, respectively. The relative regeneration efficiency values of 
the sensor #1 and #2 were removed from the data set due to drift in the SPR signal. 
Ratio 1.00 means that the regeneration process is capable to remove no more than previously 
adsorbed switchavidin and subsequent mediators from the b-SAM. Ratios lower than 1.00 
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imply roughly that the regeneration injection is unable to remove all switchavidin (and bridged 
or stably crosslinked proteins on top of the switchavidin layer) from the biotinylated SAM 
surface. Ratios higher than 1.00 instead suggest that the regeneration treatment removes more 
than only the switchavidin molecules from the gold surface. 
5.1.5 Anti-fouling ability of switchavidin layer 
The anti-fouling ability of the switchavidin layer was assessed by injecting the single protein 
solutions of BSA, lysozyme, and h-IgG over the switchavidin surface, and comparing the SPR 
signal amplitudes (shown in Table 2) to general standards. Furthermore, the completeness and 
efficiency of BSA blocking was tested by blocking one flow channel twice with BSA before 
lysozyme or h-IgG injections, and comparing the signal amplitudes of BSA injections together 
as well as with the signal amplitudes obtained from the non-blocked flow channel in overall. 
The immobilization solutions of concerned proteins were assessed free from non-protein 
contaminants prior to the experiments based on the 260/280 nm absorbance ratios that were 
close to 0.57 (Raynal et al. 2014). The mean fouling levels for BSA and lysozyme were 
obtained from two sensors with six repeats and they were reported in mDeg with corresponding 
sample standard deviations.  
The highest mean fouling amplitude (0.6 mDeg) was observed for the first injection of 
lysozyme on the non-blocked switchavidin surface. This corresponds roughly to 6 pg mm-2 or 
0.3 % percent adsorption on the average switchavidin monolayer (~ 211 mDeg). The second 
BSA injection (2nd BSA) gave the same signal response within the sensor as the first BSA 
injection (1st BSA) on the intact switchavidin layer. 
Table 2. The fouling levels of the switchavidin layer against BSA and lysozyme on BSA-
blocked and non-modified surface in mDeg. Arithmetic mean and sample standard deviation 
(SD) were calculated for the fouling levels at the different stages of the adsorption layer. 
Asterisk (*) denoted values were excluded from the data set due to drift in the SPR signal. 
 Fouling level (mDeg)   
Sensor #1 #2   
Cycle 1 2 1 2 3 4 
Mean 
(mDeg) 
SD 
(mDeg) 
1st BSA 1.7 0.0 0.0 * 0.5 0.2 0.5 0.7 
2nd BSA 1.7 0.0 0.0 0.5 0.5 * 0.5 0.7 
1st Lysozyme (BSA blocked) 0.5 0.2 1.0 0.8 * 0.0 0.5 0.4 
2nd Lysozyme (BSA blocked) 0.5 0.2 0.0 -1.1 * 0.2 0.0 0.6 
1st Lysozyme (non-blocked) 0.5 0.0 1.0 0.4 1.2 0.5 0.6 0.4 
2nd Lysozyme (non-blocked) 0.0 0.0 0.2 -0.3 0.3 -0.3 0.0 0.2 
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The mean fouling levels of lysozyme on the BSA-blocked surface were 0.5 mDeg after the first 
lysozyme injection and 0.0 mDeg after the second lysozyme injection. The mean fouling levels 
of lysozyme on the non-blocked surface were 0.6 mDeg after the first lysozyme injection and 
0.0 mDeg after the second lysozyme injection. 
The mean fouling levels for BSA and h-IgG (presented in Table 3) were obtained from two 
sensors with four repeats and they were reported in mDeg with corresponding sample standard 
deviations. 
The highest mean fouling amplitude (3.0 mDeg) was observed for the h-IgG injection on the 
non-blocked switchavidin surface. This corresponds roughly to 30 pg mm-2 or 1.4 % percent 
adsorption on the average switchavidin monolayer (~ 211 mDeg). The response of the second 
BSA injection (2nd BSA) after the first BSA blocking (1st BSA) of the intact switchavidin 
layer was ambiguous. The mean fouling levels of h-IgG on the BSA blocked and non-blocked 
surfaces were 1.4 mDeg and 3.0 mDeg, respectively. 
Table 3. The fouling levels of BSA and h-IgG on BSA-blocked and non-blocked switchavidin 
layers in mDeg. Arithmetic mean and sample standard deviation (SD) were calculated for the 
fouling levels at the different stages of the adsorption layer. Asterisk (*) denoted values were 
excluded from the data set due to drift in the SPR signal. 
 Fouling level (mDeg)   
Sensor #1 #2  
Cycle 1 1 2 3 Mean (mDeg) SD (mDeg) 
1st BSA  1.5 0.7 1.8 -0.3 0.9 0.9 
2nd BSA 2.4 -0.7 0.0 1.3 0.8 1.4 
h-IgG (BSA blocked) -3.3 6.0 * * 1.4 6.6 
h-IgG (non-blocked) 1.0 5.0 * * 3.0 2.8 
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5.1.6 Kinetics of biotinylated protein G – anti-PSA interaction 
The reference flow channel was passivated with biotinylated BSA, the active flow channel was 
activated with biotinylated protein G, and the binding kinetics between the Fc fragment of the 
anti-PSA molecule and the IgG-binding domains of the biotinylated protein G molecules was 
measured by injecting an applicable range of anti-PSA dilutions over a freshly constructed 
sensing surface.  
The truthful binding model for the biotinylated protein G – anti-PSA interaction lie somewhere 
between a simple Langmuir (OneToOne) fitting model and more complex bivalent 
(TwoToOne) fitting model due to the binding stoichiometry of the Fc fragment, and the 
heterogeneity in the spacing of the mediator molecules. This ultimately led to the presentation 
of both Langmuir and bivalent fitting for the interaction curves. Association and dissociation 
constants as well as affinity, Bmax and Chi
2 values were reported with corresponding deviations 
only at wavelength 785 nm.  
The immobilization solutions of biotinylated protein G, biotinylated BSA and anti-PSA were 
confirmed free from nucleic acid contaminants prior to the experiments based on the 
260/280 nm absorbance ratios, which were close to 0.57 (Raynal et al. 2014). 
Applicable measurement data was obtained only from a single anti-PSA dilution series.  
The immobilization levels of the biotinylated protein G and biotinylated BSA were 44 mDeg 
and 101 mDeg, respectively. The interaction kinetics measured between biotinylated protein G 
and anti-PSA was fitted in Langmuir (Figure 13) and bivalent (Figure 14) adsorption models, 
and the calculated kinetic constants were presented with corresponding standard deviations. 
The quality of fittings was evaluated further based on the residual plots presented in Figure 15 
and Figure 16. 
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Figure 13. Kinetic curves of the biotinylated protein G – anti-PSA interaction measured for 
67 pM – 20 nM concentration range (colored curves) and fitted in a Langmuir model (black 
curves). Signal levels of adsorption are presented in mDeg. Association and dissociation rate 
constants (ka and kd) as well as the dissociation constant (KD), maximum signal response that 
ligands can generate (Bmax), and Chi
2 values are reported with corresponding deviations. 
 
Figure 14. Kinetic curves of the biotinylated protein G – anti-PSA interaction measured for a 
67 pM – 20 nM concentration range (colored curves) and fitted in bivalent model (black 
curves). Signal levels of adsorption are presented in mDeg. Association and dissociation rate 
constants (ka and kd) as well as dissociation constant (KD), and maximum signal response that 
ligands can generate (Bmax) are reported for the monovalent and divalent phase of the interaction 
with corresponding deviations and Chi2. 
ka = (773 ± 71) x 103 M-1 s-1 
kd = (593.00 ± 0.05) x 10-6 s-1 
KD = (766 ± 71) x 10-12 M 
Bmax = (20.610 ± 0.007) mDeg 
Chi2 = 0.99 (mDeg)2 
Range = 67 pM – 20 nM
ka1 = (350.00 ± 0.03) x 103 M-1 s-1 
kd1 = (2.80 ± 0.02) x 10-3 s-1 
KD1 = (7.99 ± 0.06) x 10-9 M 
ka2 = (14.9 ± 17.6) x 10-3 mDeg-1 s-1 
kd2 = (99.9 ± 0.4) x 10-3 s-1 
KD2 = (6.7 ± 20.5) mDeg 
 Bmax = (41.85 ± 0.03) mDeg 
Chi2 = 0.48 (mDeg)2 
Range = 67 pM – 20 nM 
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Figure 15. The residual signal of Langmuir fitting performed for the biotinylated  
protein G – anti-PSA interaction. The residual signal was reported in mDeg with corresponding 
coloring of concentrations as in Figure 13. 
Small systematic differences between the curve fitting and the measured curves were seen for 
the Langmuir fitting (shown in Figure 13) of the anti-PSA injections having higher 
concentrations than 1 nM (cyan fitting curve). 
 
Figure 16. The residual signal of bivalent fitting performed for the biotinylated  
protein G – anti-PSA interaction. The residual signal was reported in mDeg with corresponding 
coloring of concentration as in Figure 14. 
 48 
Similar although smaller differences between the curve fittings and the measured curves were 
seen for the bivalent fitting (shown in Figure 15) than for the Langmuir fitting (shown in  
Figure 16) of the anti-PSA injections at higher concentrations than 1 nM (cyan fitting curves). 
5.2 Interaction kinetics of sulfonamide hCAII inhibitors 
5.2.1 Immobilization of hCAII enzyme 
The human CAII enzyme was immobilized into a carboxymethylated dextran matrix using the 
EDC/NHS amine coupling chemistry in order to measure the interaction kinetics of hCAII with 
three inhibitors. The immobilization level of hCAII used in the successful inhibitor binding 
cycle performed with AZE was 675 mDeg. The pH of immobilization buffer was adjusted to 
5.70 based on the theoretical isoelectric point of hCAII (pI = 6.86). 
5.2.2 Detection of hCAII interaction kinetics with inhibitors  
The hCAII interaction kinetics with three inhibitors (4-CBS, AZE, and MSU) were measured 
from the lowest inhibitor concentration to the highest inhibitor concentration. Unfortunately, 
the general quality of the kinetic data was poor due to challenges associated with the enzyme 
immobilization and air bubble management. Fortunately, one applicable dataset was recorded 
for a single dilution series of AZE from a single sensor. The kinetic curves were fitted to the 
Langmuir model (presented in Figure 17). The quality of the fitting was evaluated further based 
on the residual plot shown in Figure 18.  
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Figure 17. Kinetic curves of the hCAII – AZE interaction measured for a 3 nM – 200 nM 
concentration range (colored curves without 12.5 nM dilution) and fitted in the Langmuir model 
(black curves). The cutting of the signal peaks resulted in gaps into the measurement data. 
 
Figure 18. The residual signal of Langmuir fitting performed for the hCAII – acetazolamide 
interaction data in mDeg. The cutting of the signal peaks resulted in gaps into the measurement 
data. The noise level of the enzyme-coupled sensing surface is marked with dashed lines. 
ka = (0.49 ± 0.06) x 106 M-1 s-1 
kd = (7.8 ± 0.1) x 10-3 s-1 
KD = (16 ± 2) x 10-9 M 
Bmax = (1.45 ± 0.01) mDeg 
Chi2 = 0.03 (mDeg)2 
Range = 3 nM – 200 nM
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The kinetic fitting of the hCAII – acetazolamide interaction data into the Langmuir model was 
successful in terms of calculated fitting residuals, which varied inside the noise level of the 
measurements (marked with dashed lines in Figure 18), but clear systematic deviations were 
observed in the beginning of the association and dissociation phases. 
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6 DISCUSSION 
6.1 Immunosensing platform with stepwise regeneration 
6.1.1 Stability of instrument and b-SAM 
The stability of the instrument and b-SAM was assessed based on the baseline drifts observed 
in the SPR peak minimum angle measurements. The origin of baseline drift often remains 
unclear, but it may be attributed to the fluctuations in the flow cell temperature or the 
contaminants in the fluidic system as well as the buildup of gas onto the sensing surface or the 
instability of molecules bound on the gold surface (BiacoreTM Assay Handbook 2012).  
The measurements were performed with sterile filtered PBS running buffer at a constant flow 
rate after thorough cleaning of the instrument and stabilization of experiment conditions.  
Prior the experiment, the thermal drift was minimized with RT equilibrated running buffer and 
the flow cell temperature was stabilized with a Peltier-type temperature controller that is 
capable of adjusting flow cell temperature both upwards and downwards. The buildup of gas 
onto the b-SAM surface was reduced using RT equilibrated running buffer that was degassed 
by tapping the buffer filled plastic syringe under negative pressure. The buildup of residual gas 
was followed by monitoring the PMI signal, and the stability of PMI signal was exploited when 
a 30-min time period was selected for the baseline drift analysis. 
The directional comparison of recorded baseline drifts can be made with the instrumental drift 
reported on the specifications of the 210A VASA MP-SPR Navi™ instrument. The baseline 
drifts were measured from three sensor slides. The sensor-specific baseline drift values were 
higher for the 670-nm wavelength lasers than for the 785-nm wavelength lasers. The mean 
baseline drifts of the upper and lower flow channel reported at 785 nm-wavelength lasers for 
comparability with the reference system of Biacore were on average 0.12 mDeg min-1 and 
0.16 mDeg min-1, respectively. Those values are very close to the reported instrumental drift 
(> 0.1 mDeg min-1) when the additional b-SAM molecular layer of the studied sensing surface 
is taken into account.  
Small and systematically occurring differences in the sensor-specific baseline drifts between 
the flow channels could be explained with the inaccuracies in the specified wavelengths of the 
lasers (Zhang et al. 2003). This would lead to the divergent sensitivities of the measurement 
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spots to the fluctuations in the experiment conditions. It was estimated that the variation 
between the laser wavelengths could be in the range of ±5 nm (Tony Stoor, BioNavis, personal 
communication). The dependence of the baseline drift on the wavelengths of lasers could be 
simply tested in future studies by comparing the flow channel-specific baseline drift results 
together when the sensor slide is rotated in the sensor holder i.e. the flow channels are 
transposed. Small, although visible, deviations between the specified wavelength of different 
flow channels are difficult to eliminate in ultrasensitive sensing systems, but fortunately the 
relevance of the effects on the immunosensing applications is marginal. 
In summary, the carefully performed priming and conditioning with high quality buffer and 
accurate temperature control of the flow cell resulted in sufficiently low baseline drift for the 
combination of b-SAM and the instrument in comparison with the instrumental drift.  
This provides a secure platform for the construction of mediator and ligand layers, but the 
statistical significance of the results cannot be defined due to the low number of measured 
sensor slides.  
6.1.2 Immobilization levels of switchavidin 
The purity as well as integrity and homogeneity are crucial properties for the immobilization 
solutions of proteins in terms of valid immobilization levels and interaction kinetics. The purity 
and integrity of the switchavidin protein solutions had been qualified using a SDS-PAGE 
method and a UV-Vis spectrophotometer, but the purity from non-protein contaminants was 
reassessed as pure based on the absorbance ratio A280/260 measured by a UV-Vis 
spectrophotometer (http://biomeditech.fi/Protein_Shop/switchavidin.html; July 1, 2017).  
Dynamic light scattering (DLS) would have provided information about the homogeneity of 
switchavidin solution by measuring the monodispersity based on the size of the particles. 
The determination of monodispersity for the switchavidin immobilization solution would have 
ensured that the switchavidin molecules are consistently in a soluble tetrameric state, and that 
the protein handling or the storage conditions of the protein solution have not formed 
aggregates. (Raynal et al. 2014) 
The mean switchavidin immobilization levels for the upper and lower flow channels were 
210.2 (SD 7.9) mDeg and 212.2 (SD 8.9) mDeg, respectively. These values were lower than 
the reference adsorption level (2416 ± 8 RU i.e. response units that roughly corresponds to 
241.6 ± 0.8 mDeg) reported in the original article of Taskinen et al. 2014, where switchavidin 
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was studied comprehensively for the first time. The overall repeatability of the switchavidin 
layer was good as the corresponding coefficients of variation (CV; ratio of SD and arithmetic 
mean) were 3.7 % and 4.2 % for the upper and lower flow channel, respectively. The deviations 
in the immobilization level and repeatability of switchavidin binding may originate from the 
changes in the b-SAM deposition, which was not so optimized, but practically more 
straightforward. The challenges associated with the b-SAM quality are discussed later in the 
regeneration section. Further, the differing wavelengths of the instruments (785 nm for the MP-
SPR and 760 nm for the Biacore setup) affect the sensitivity of the detection system, and 
correspondingly, the observed levels (in mDeg) of switchavidin binding. 
The statistical analysis of the flow cell-specific switchavidin immobilization levels did not 
show a statistically significant relation between the flow channels so the quality of b-SAM 
surfaces seemed consistent within a single sensor. The statistical analysis done for the sensor-
specific values instead revealed statistically significant difference between the sensors. 
This may result from numerous reasons related to the quality of the switchavidin 
immobilization solution or the b-SAM membrane.  The poor batch-to-batch quality of the gold 
layer e.g. due to surface defects may expose the gold surface for the non-specific adsorption of 
switchavidin as the surface changes are neutralized that lead to more hydrophobic adsorption 
behavior. Furthermore, the defects on the gold layer as well as the variation in the oxidation 
state of the gold surface during the b-SAM deposition process may lead to an erratic and 
therefore unstable b-SAM that may lose biotinylated b-SAM components during  
the regeneration cycles (Srisombat et al. 2011). 
The decreasing trend observed in the scatter plot of sensor-grouped switchavidin 
immobilization levels shown in Figure 9 indicates probably the incomplete regeneration of the 
sensing surface from adsorbed switchavidin molecules in the previous cycle, or the previously 
described effects of surface defects and oxidation states during the b-SAM surface production 
phase. This subsequently leads to a lower immobilization level in the next cycle until there is 
space available only for reversible interactions. A similar trend was seen in the Figure 12, which 
describes the relative regeneration efficiency of the switchavidin layer. 
In summary, the switchavidin binding on the b-SAM was assessed as a repeatable and 
reproducible process. The surface quality of the b-SAM was consistent within the sensor slide, 
but minor statistical deviation was seen between the sensor slides. It should be noted that the 
possible sources of batch-to-batch variation, such as the oxidation state and surface quality of 
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the gold layer, may explain the statistical significance of the sensor-specific results, and they 
can be corrected easily by optimizing the manufacturing process (Mockus et al. 2014).  
A downward trend was observed for the switchavidin adsorption cycles, which may be 
explained by the variation in the gold and b-SAM surface qualities. 
6.1.3 Mechanical adsorption model of switchavidin 
The high affinity biotin-avidin-biotin bridges provide a robust way to immobilize ligands in 
biomedical, biosensing, and biotechnological applications. This, however, requires the stable 
divalent binding of avidin molecules on the biotinylated surface as the monovalent binding is a 
reversible process. The binding valency of avidin molecules has been studied recently by 
changing the surface coverage of biotin residues (Ray et al. 2015) as well as with purpose-
designed synthetic streptavidin constructs that have lower number of biotin binding sites, but 
retained binding affinity (Dubacheva et al. 2017). These approaches utilized a quartz crystal 
microbalance with dissipation (QCM-D) and spectroscopic ellipsometry (SE) to produce 
reliable quantitative information about the binding valency of avidin molecules  
(Dubacheva et al. 2017).  
This section tries to apply the described explanations into the MP-SPR measurement results 
obtained for the adsorption of switchavidin onto the biotinylated SAM surface. The aim is to 
expand the knowledge about the adsorption behavior of surface charge neutralized avidins and, 
in a broader context, to assess the suitability of the MP-SPR detection system for similar 
molecules that bind multivalently on the planar surface. From a commercial point of view,  
the reliable and real-time assessment tool for the binding valencies would benefit the 
development and quality assurance of multivalent ligands and corresponding surfaces.  
Further, it would improve the reproducibility and automation of different bioassays by 
providing complete monolayers of mediator or ligand molecules with less manual optimization. 
In the first step, the switchavidin molecules bind randomly to biotin residues of b-SAM surface, 
and the protein covered area and the density of the adsorption layer increases. This process has 
been observed as a negative shift in the resonance frequency and as a positive shift in the 
dissipation energy and the ellipsometric surface coverage in the earlier studies for the 
streptavidin (Dubacheva et al. 2017) and the neutralized chimeric avidin (NCAvd) (Ray et al. 
2015). The increase in the packing density of proteins i.e. the density of the adsorption layer, 
was probably detected during the switchavidin adsorption as an increase in the PMI signal as 
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this is sensitive to the optical scattering of the biomolecular layer (presented in 
Figure 10) (Viitala et al. 2013). The lateral interactions between the surface-bound neutralized 
switchavidin molecules may lead to a positive co-operation of switchavidin binding, and to a 
subsequent initiation of island formation (Rabe et al. 2011). Due to the immobile structure of 
b-SAM, this is, however, largely a local phenomenon in comparison with a mobile biotinylated 
supported lipid bilayer (b-SLB), in which biotinylated lipids can move by lateral diffusion 
(Reviakine and Brisson 2001). 
Then, the switchavidin covered area and the fractional population of monovalently bound 
switchavidin molecules reach their maximum values. Simultaneously, the switchavidin 
molecules continue to minimize their energy state in a transitional phase, where the 
monovalently bound switchavidin molecules proceed towards multivalently bound 
switchavidin molecules. An overshoot peak and a subsequent decrease were observed in the 
dissipation shifts of the QCM-D systems during the association phase of switchavidin when the 
surface coverage of biotin residues in the b-SAM was higher than 0.5 % (Dubacheva et al. 2017 
in Figure 5A; Ray et al. 2015 in Figure 6). These responses were also seen in the PMI signal of 
MP-SPR (presented in Figure 10). When the dissipation shift of QCM-D was plotted as a 
function of surface coverage measured with SE, the height of the overshoot peak lowered as 
the surface density of biotin residues increased (Ray et al. 2015 in Figure 8). This suggests that 
there is a structural difference between the adsorption layers formed on surfaces with high and 
low biotin content. Interestingly, a similar decline in the height of the overshoot peak was 
observed with the increasing number of regeneration cycles done for the switchavidin layer. 
The decrease after the overshoot peak indicates consistently a continuous mechanical 
stabilization of switchavidin molecules e.g. via protein – protein interactions as well as an 
entropy-driven hydrodynamic process, where the protein surface-bound water molecules 
dissociate during the adsorption onto the b-SAM surface (Bingen et al. 2008). 
The critical packing density is achieved when a major part of the monovalently bound 
switchavidin molecules have been replaced by switchavidin molecules showing divalent 
binding. At this point, the protein – protein interactions increase significantly, which may 
trigger orientational changes in the switchavidin layer to optimize the electrostatic repulsions 
and attractions. Such reorganization may increase the total binding energy within the adsorbing 
protein molecules as well as of the solid surface – protein interactions (Rabe et al. 2011). This 
was potentially observed as a small although repeatable (N = 14) elevation in the PMI signal 
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(presented in Figure 10 with grey arrows). The shape of the dissipation shift during the 
adsorption of tetrameric streptavidin onto the b-SAM surface and, more clearly, onto the b-SLB, 
support this finding (Dubacheva et al. 2017 in Figures 5A and 5B). A similar trend was also 
seen during the adsorption of NCAvd onto the b-SAM surfaces with the surface coverage of 
biotin higher than 0.5 % (Ray et al. 2015). At the same time point when the critical packing 
density was achieved, the saturation limit of b-SAM was found for the switchavidin binding 
according to the new baseline of SPR peak minimum angle. 
Granqvist and colleagues observed in 2013 a highly reminiscent overshoot effect in a similar 
but reversed system (labeled biotin binds surface immobilized avidin) measured with equivalent 
MP-SPR instrumentation. They suggested that the overshoot peak in the label-enhanced 
absorbance was caused by the sample plug of labeled biotin injection. Alternatively, a surface 
crystallization of avidins could explain the changes in the PMI as the optical scattering of the 
biomolecular layer increases as the size of protein clusters increases. This does not, however, 
provide explanation for the kinetic profile of switchavidin adsorption (Raynal et al. 2014). 
The sensorgram of switchavidin adsorption onto the b-SAM surface included atypical 
adsorption profile (shown in Figure 19) that may originate from the low amounts of detergent 
residuals left into the immobilization solution of switchavidin (BiacoreTM Assay Handbook 
2012). The purification of switchavidin had been performed with hand washed laboratory 
glassware, which may explain the residuals of detergents. The existence of detergents in the 
immobilization solution may affect the surface chemistry related to the adsorption mechanism. 
Therefore, the buffer exchange of the switchavidin solution would be an essential step in future 
studies if the mechanical adsorption model is studied more. 
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Figure 19. Schematic sensorgram showing typical detergent effect. The normal exponential 
binding curve is illustrated with grey dashed line. The figure was recreated based on BiacoreTM 
Assay Handbook (2012). 
To conclude, the MP-SPR detection system is not intended to provide a conclusive explanation 
to the multivalent adsorption behavior of switchavidin or avidin proteins, but rather to support 
the similar observations achieved with non-optical methods, such as QCM-D. The analysis of 
PMI signals deriving from the switchavidin adsorption event gave a strong direction for further 
studies related to the MP-SPR detection of multivalent binding. The binding valency of 
switchavidin could be studied more by alternating the surface coverage of biotin residues in the 
b-SAM as well as by using suitable reported molecules with proper controls as described in two 
reference articles earlier in this section (Ray et al. 2015; Dubacheva et al. 2017). The qualitative 
surface analysis of adsorbed proteins could be performed for example by atomic force 
microscopy (AFM) that would also provide adhesion and cohesion energy for  
the protein – protein and protein – surface interactions (Rabe et al. 2011), or by fluorescent 
microscope techniques, when biotinylated fluorescent tags e.g. biotin–4-fluorescein, are 
utilized (Taskinen et al. 2014). 
6.1.4 Regeneration of immunosensing platform 
According to the reference study presented by Zauner et al. in 2016, the normal regeneration 
of biotinylated protein G – anti-PSA interaction was relatively successful as only 2.4 % of 
switchavidin was found to be removed per cycle for the first two cycles. Further, this amount 
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decreased to 0.9 % for the subsequent cycles. The most probable reason for this decrease after 
the first two cycles is the desorption of unstable fractions of switchavidin by the normal 
regeneration solution. The obtained results were slightly better than the corresponding value 
calculated from the values reported in the reference studies, that is, 7.8 % 
(= 18.8 mDeg / 241.6 mDeg) (Zauner et al. 2016). The impact of non-specific switchavidin 
desorption was marginal as the reference flow channel (blocked with biotinylated BSA) acted 
in a similar way, and the referencing step was fully applicable. 
The first rigorous regeneration of the switchavidin surface either left small residual amounts of 
proteins on the b-SAM, or alternatively resulted in a removal of all proteins from the b-SAM, 
or a tiny amount of biotinylated SAM components (as shown in Figure 11). After the first cycle, 
the amount of switchavidin residuals was on average +3.7 (SD 2.93) mDeg (CV 79 %) for the 
next few cycles that were performed. It is worth noticing that the reported sensor-specific 
baseline shift values for rigorous regeneration are unequal due to varying protein compositions 
on top of the switchavidin that may cross-link and prevent switchavidin molecules from 
desorbing locally. 
The regeneration efficiency ratio in Figure 12 stabilized to 1.00 after sixth cycles, which means 
that all the adsorbed switchavidin molecules have been removed successfully from the b-SAM 
surface. From the perspective of assay development, it seems that the constant level of adsorbed 
switchavidin was found after the sixth cycle. This does not, however, reveal the adsorption 
mechanism (specific biotin-switchavidin interaction versus non-specific) of the switchavidin 
nor the amount of oriented i.e. available switchavidin. 
In conclusion, the normal regeneration was efficient with a sufficient resolution to the rigorous 
regeneration. The first two normal regeneration cycles most likely removed a small fraction of 
weakly bound switchavidin. The use of accurate imaging techniques, such as AFM at different 
stages (e.g. the gold layer before and after b-SAM deposition as well as the b-SAM surface 
between the switchavidin immobilization and rigorous regeneration cycles), would shed some 
light on the real processes of sensing surface regeneration. 
6.1.5 Anti-fouling ability of switchavidin layer 
The switchavidin layer demonstrated clear ultra-low fouling ability against single protein 
solutions of BSA, lysozyme, and h-IgG based on the mean fouling SPR signal amplitudes 
(Brault et al. 2012). More closely, the mean fouling levels were lower than the specified 
 59 
adsorption level of 5 mDeg, which corresponds roughly to 50 pg mm-2 or 2.4 % percent 
adsorption on the average switchavidin monolayer (~ 211 mDeg) (Vaisocherová et al. 2015). 
This result was in accordance with the results reported in the reference article of Zauner et al. 
(2016). Furthermore, the percent adsorption of lysozyme (0.2 %) was lower than that reported 
for the pure EG3 SAM membrane (1 %), which indicates that the switchavidin monolayer 
improve the anti-fouling property of the system sensing surface 
(https://www.prochimia.com/products/product/1; July 22, 2017). 
The completeness of the BSA blocking process remained unclear due to a large sensor-specific 
variation between the fouling levels of first and second BSA injection presented in Table 3. 
This variation could be explained with the surface defects on the gold layer and inconsistences 
on the SAM surface as noted in the immobilization and regeneration sections of switchavidin. 
Furthermore, the signal analysis of protein fouling was complicated due to low signal levels 
and strong downwards directed drifting. Incomplete i.e. a loosely packed BSA adsorption layer 
may lead to this drifting effect as a result of desorbing BSA molecules, and ultimately may 
compromise the stability of the sensing surface (Rabe et al. 2011).  
In summary, the switchavidin layer that was bound on the b-SAM has ultra-low fouling 
properties against the single-protein solutions of BSA, h-IgG, and lysozyme. Overall, the total 
number of cycles was clearly insufficient to make statistical evaluations concerning the 
efficiency of BSA blocking or the anti-fouling ability against BSA, lysozyme, or h-IgG.  
The achieved results can be exploited only to guide further research. Next steps would be the 
confirmation of results with statistical significance. After that one can proceed to 
multicomponent protein solutions that mimic more closely the adsorption behavior of complex 
media, such as blood serum. 
6.1.6 Kinetics of biotinylated protein G – anti-PSA interaction 
The injections of anti-PSA dilutions were too short to analyze the kinetics and affinity of the 
anti-PSA – biotinylated protein G interactions reliably because the equilibrium phase of the 
interaction was not achieved. The results were obtained only from a single sensor so the 
statistical analysis of results was impossible and the quality of the Langmuir and bivalent 
fittings were poor. The reported kinetic values are, therefore, not very reliable. Chi2-values are 
reasonable low, although, certain upper limit cannot be set for the Chi2-value.  
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The chosen IgG (anti-PSA) from Medix Biochemica showed relatively strong affinity to the 
biotinylated protein G molecule based on the Langmuir model fitting shown in Figure 13.  
The dissociation constant was (0.766 ± 0.071) nM, which was consistent with the reference 
value of Zauner et al. (2.0 nM). The dissociation times were between 30 min to 1 hour 
depending on the concentration of the anti-PSA based dissociation curves in Figure 13.  
The bivalent model gave a visually slightly better fit (shown in Figure 14) than the simple 
Langmuir model for the anti-PSA binding to biotinylated protein G molecules. This is most 
likely due to the “flexibility” of fitting algorithm used in the bivalent model. In fact, the closer 
inspection of kinetic parameters calculated for the bivalent phase of the binding showed that 
the standard deviations were relatively high and the bivalent model may not conform to what 
is happening on the sensing surface. 
The residual plots for both kinetic fittings (Figure 15 and 16) showed a systematic deviation 
between the two highest and the rest of the anti-PSA concentrations, which may indicate the 
incapability of the available models to interpret the experimental situation 
(https://www.sprpages.nl/data-fitting/validation; July 22, 2017). The deviation was higher for 
the Langmuir model fitting than for the bivalent fitting, which may originate from the earlier 
mentioned flexibility of the fitting algorithm. The deviations in the interaction kinetics may 
originate from the aggregates or protein clusters of antibodies that interfere with the specific 
binding event on the biotinylated protein G layer (Rabe et al. 2011). 
In conclusion, the bivalent model gave a better kinetic fit than the Langmuir model to some 
extent, but only for a single dilution series that inevitably cause uncertainty to the kinetic 
calculations. Overall, more measurement cycles are required with the higher concentration of 
antibodies under systematic quality control to assess the applicability of the immunosensing 
platform as well as to achieve more reliable kinetic results (Raynal et al. 2014). 
6.2 Interaction kinetics of sulfonamide hCAII inhibitors 
6.2.1 Immobilization of hCAII enzyme 
The human carbonic anhydrase II enzyme (pI = 6.86; theoretical) was selected for the 
experiments instead of bovine carbonic anhydrase II (pI = 5.88; Rogez‐Florent et al. 2014) as 
this resembles more closely the pharmacodynamics of human targeted CAII drugs.  
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The isoelectric points of these two allozymes were different so the pH of the hCAII 
immobilization solution was adjusted to pH 5.7 based on the standard operation procedure 
commonly used for the EDC/NHS amine coupling chemistry. The amine coupling chemistry 
interfering compounds, such as Tris-SO4 and sodium azide, were removed from the hCAII stock 
solution by centrifugal ultrafiltration. The immobilization of hCAII at specific conditions 
resulted in an immobilization level of 675 mDeg, which was consistent with the immobilization 
level reported in the reference article of Papalia et al 2006 (690 mDeg on average).  
The dissociation constant of the hCAII – inhibitor interaction was assumed practically as 
independent on the level of enzyme immobilization based on the experimental data presented 
in the literature for the bovine CAII enzyme (Cannon et al. 2004). The pre-concentration testing 
conducted in further studies, however, revealed that the optimal pH for the hCAII 
immobilization solution could have been between pH 6.1 and 6.5 (data not shown). 
Unfortunately, the subsequent immobilization rounds failed in other ways e.g. due to air-bubble 
problems. 
6.2.2 Detection of hCAII interaction kinetics with inhibitors  
The main technical challenges in the pharmacodynamic studies of carbonic anhydrase inhibitors 
are related to the fast association kinetics of sulfonamide inhibitors (even in the order of 
106 M-1 S-1 for AZE) combined with a small size of the inhibitor molecule (less than 400 Da) 
(Papalia et al. 2006).  Furthermore, sulfonamide-based inhibitors are insoluble in water per se. 
Therefore, DMSO is used in the stock solution preparations as a standard operation procedure. 
The AZE inhibitor was, however, assessed as fully soluble in PBS with 3% of DMSO as the 
experiments conducted in the earlier study also without DMSO did not show a difference 
between the kinetic sensorgrams for the bovine CAII (Cannon et al. 2004). 
Moderate quality kinetic data was obtained only from a single sensor with one dilution series 
for the AZE inhibitor due to the practical problems in the immobilization of hCAII as well as 
in the air bubble management. At first, the dissociation rate constant was fitted separately 
resulting in (7.8 ± 0.1) x 10-3 s-1. Then this was set as constant in the global Langmuir model 
fitting (presented in Figure 17). The additional mass transport term that was applied in the 
reference article of Papalia et al. in 2006 did not improve the Langmuir model fitting at any 
respect so it was not used in the kinetic analysis. The fitting algorithm did not find the 
association phase of the curves well, which caused some inaccuracy to the results. The Bmax in 
turn was found accurately. The signal residuals obtained for the global Langmuir fitting of the 
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hCAII - acetazolamide interaction data (shown in Figure 18) were in the same level with the 
noise recorded for the enzyme-coupled sensing surface. This suggests that the instrumental 
noise does not limit the resolution of kinetics significantly in this system. The shape of the 
residuals, however, pointed out systematic deviations at the beginning of association and 
dissociation phases that suggests inadequate ability of the fitting algorithm to describe the 
interaction phenomenon fully. 
The dissociation constant for the hCAII – AZE interaction was (16 ± 2) nM. This value was in 
accordance with the reference value of (20 ± 1) nM reported by Rogez-Florent et al. in 2013. 
The observed association [(0.49 ± 0.06) x 106 M-1 s-1] and observed dissociation 
[(7.8 ± 0.1) x 10-3 s-1] of AZE were slower than the reference values: 
ka = (1.7 ± 0.7) x 10
6 M-1 s-1 and kd = (7.8 ± 0.1) x 10
-3 s-1. This may result from diffusion-
limited kinetics and re-binding of AZE molecules with hCAII enzymes in the thick CMD 
matrix, which ultimately affects both the association and dissociation rate constants in a similar 
extent and leave dissociation constant (KD = kd / ka) unaltered (Papalia et al. 2006). In the 
protocol of Rogez-Florent et al. (2013), the effect of MTL was minimized by using a flow rate 
of 100 µl min-1, which suggests that the difference originates possibly from the MTL present in 
the experiment setup. 
The rapid association phase of the AZE binding requires a very good time resolution of the SPR 
instrument. The MP-SPR Navi™ instrumentation utilizes the angular scan to record the full 
SPR curve and to monitor RI changes in the bulk phase, which in turn lowers the time resolution 
and complicates the detection of fast association kinetics. In the case of AZE, it was, however, 
possible to measure association kinetics in the scale of 105 M-1 s-1. Sometimes, the disadvantage 
related to the angular scan can be compensated with a PureKinetics™ tool (BioNavis) that 
subtracts the TIR change directly from the SPR peak minimum angle, and helps to distinguish 
the association curvature from the bulk change. The low signal levels of small molecules, 
however, emphasize the combined noise level deriving from both the TIR angle signal as well 
as the peak minimum angle signal resulting in low signal-to-noise ratio. Therefore, 
PureKinetics™ tool was not applicable in this context. The fixed angle mode that can be applied 
also in the MP-SPR Navi™ instrumentation improves the time resolution of measurement 
significantly. 
The serial injection of the running buffer (3 % DMSO in PBS) from the 96-well plate showed 
unusually high bulk effect in both the active and reference channel of the sensorgram (not 
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shown) despite the intensive washing procedures performed for the fluidic system.  
This indicates the excluded volume effect that was corrected in the reference article of Papalia 
et al. 2006 with a calibration series of DMSO. Alternatively, the use of deactivated recombinant 
(mutated) or denatured form of hCAII in one of the reference channels could alleviate the 
problem. 
In the original protocol of Papalia et al. 2006, the re-sealable soft rubber caps with glass vials 
were used. In this experimental work, the plastic 96-well-plates were used without any film to 
cover the wells filled with analyte dilutions. Furthermore, it was noted later that the buffer 
containers turned their color from white to yellowish after a few days’ storage of running buffer 
containing 3% DMSO. Despite the effort to prepare samples and buffers right before use,  
the evaporation and absorption to plastics may have affected the results. This should be taken 
into consideration in further studies. 
In conclusion, the detection of rapid small molecule interaction kinetics was clearly dependent 
on the performance of a 4-channel MP-SPR prototype in terms of instrumental noise and time 
resolution, but the successful immobilization of hCAII into CMD matrix, the stabilization of 
the sensing surface and the careful preparation of buffers and analyte dilutions play a key role 
for the visible binding kinetics as well. In future studies, it should be noted that correction of 
the excluded volume effect as well as the optimization of sample preparation regarding the right 
use of DMSO may improve the quality of kinetic data. The effect of MTL could be reduced by 
increasing the flow rate, e.g. to 100 µl min-1. The fixed angle mode would also provide a higher 
sampling frequency. 
 64 
7 CONCLUSIONS 
The regenerable and stable immunosensing platform based on the switchavidin and protein G 
molecules was reconstructed. This system showed high repeatability and reproducibility in 
terms of baseline drift of b-SAMs, switchavidin immobilization, regenerability, and 
anti-fouling ability. The affinity immobilization of antibodies to the biotinylated protein G 
monolayer requires more research with higher concentrations of high-quality antibodies to 
achieve the saturation limit that enables the higher sensitivity of the immunoassay system.  
The stability of mediator molecules as well as the binding valency between the biotinylated 
protein G and IgG molecules will determine the expected detection limit and the stability of the 
immunosensing platform. The antifouling ability of the immunosensing platform could be 
tested with multicomponent protein solutions in the next phase to evaluate the resistance against 
the cooperative non-specific binding of proteins.  
The systematically repeating overshoot peak, logarithmic decrease, and small elevation in the 
PMI signal during the switchavidin adsorption was supported by similar observations found 
from the literature (Ray et al. 2015; Dubacheva et al. 2017). The mechanical adsorption model 
based purely on previous findings suggests that the MP-SPR might enable the monitoring of 
the multivalent binding process of switchavidin (overshoot peak and logarithmic decrease) as 
well as the optimization of protein – protein and protein – surface interactions (elevation).  
The development and quality assurance of multivalent ligands and corresponding surfaces 
would benefit from the real-time evaluation of multivalent binding processes. Further, the real-
time monitoring of multivalent binding would improve the reproducibility and automation of 
different bioassays by providing complete monolayers of mediator or ligand molecules with 
less manual optimization. The proposed adsorption model, however, requires complimentary 
data measured for instance by AFM or fluorescent microscope techniques to validate the 
observations. 
The kinetics of the hCAII enzyme – sulfonamide inhibitor interaction was resolved for AZE by 
immobilizing the hCAII enzyme into a CMD matrix and introducing the dilutions series of AZE 
with specified association and dissociation time. Notably, the physico-chemical conditions, 
where the carbonic anhydrase immobilization was performed, were different between the 
alloenzymes of human and bovine, most likely due to clearly differing isoelectric points 
(6.86 and 5.88, respectively). The kinetic data was measured using MP-SPR instrument of 
 65 
BioNavis company in the angular scan mode. The time resolution of the angular scan seemed 
sufficient to record the rapid association kinetics of sulfonamide inhibitors in the scale of 
105 M-1 s-1 for AZE. The unique PureKinetics™ tool was able to filter out some of the bulk 
signal. However, the small MW of sulfonamide inhibitors in addition to the plausible excluded 
volume effect of DSMO resulted in a low signal-to-noise ratio, and the overall quality of kinetic 
data was poor. The kinetic analysis, with kinetic values in the same range as those reported in 
literature, demonstrated that the detection of fast association kinetics of small MW analytes is 
possible using the MP-SPR instrumentation. The comparison of kinetic values with the 
reference values presented in the literature also highlighted that the kinetic data may contain a 
MTL factor, which can be corrected easily by increasing the flow rate of the system. In future 
studies, it is important that the calibration curve of DMSO is applied or a non-active enzyme is 
immobilized in one of the reference channels to remove the excluded volume effect. Finally, 
the kinetic measurements should be performed at least in triplicate to achieve statistically 
significant results. 
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